<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37511491</PMID><DateCompleted><Year>2023</Year><Month>07</Month><Day>31</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>14</Issue><PubDate><Year>2023</Year><Month>Jul</Month><Day>21</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Frontotemporal Dementia, Where Do We Stand? A Narrative Review.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">11732</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms241411732</ELocationID><Abstract><AbstractText>Frontotemporal dementia (FTD) is a neurodegenerative disease of growing interest, since it accounts for up to 10% of middle-age-onset dementias and entails a social, economic, and emotional burden for the patients and caregivers. It is characterised by a (at least initially) selective degeneration of the frontal and/or temporal lobe, generally leading to behavioural alterations, speech disorders, and psychiatric symptoms. Despite the recent advances, given its extreme heterogeneity, an overview that can bring together all the data currently available is still lacking. Here, we aim to provide a state of the art on the pathogenesis of this disease, starting with established findings and integrating them with more recent ones. In particular, advances in the genetics field will be examined, assessing them in relation to both the clinical manifestations and histopathological findings, as well as considering the link with other diseases, such as amyotrophic lateral sclerosis (ALS). Furthermore, the current diagnostic criteria will be explored, including neuroimaging methods, nuclear medicine investigations, and biomarkers on biological fluids. Of note, the promising information provided by neurophysiological investigations, i.e., electroencephalography and non-invasive brain stimulation techniques, concerning the alterations in brain networks and neurotransmitter systems will be reviewed. Finally, current and experimental therapies will be considered.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Antonioni</LastName><ForeName>Annibale</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0003-1555-6418</Identifier><AffiliationInfo><Affiliation>Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Doctoral Program in Translational Neurosciences and Neurotechnologies, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Raho</LastName><ForeName>Emanuela Maria</ForeName><Initials>EM</Initials><AffiliationInfo><Affiliation>Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopriore</LastName><ForeName>Piervito</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9789-3129</Identifier><AffiliationInfo><Affiliation>Neurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pace</LastName><ForeName>Antonia Pia</ForeName><Initials>AP</Initials><AffiliationInfo><Affiliation>Institute of Radiology, Department of Medicine, University of Udine, University Hospital S. Maria della Misericordia, Azienda Sanitaria-Universitaria Friuli Centrale, 33100 Udine, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Latino</LastName><ForeName>Raffaela Rita</ForeName><Initials>RR</Initials><AffiliationInfo><Affiliation>Complex Structure of Neurology, Emergency Department, Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Casa Sollievo della Sofferenza, 71013 San Giovanni Rotondo, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Assogna</LastName><ForeName>Martina</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Centro Demenze, Policlinico Tor Vergata, University of Rome 'Tor Vergata', 00133 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Non Invasive Brain Stimulation Unit, Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia, 00179 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mancuso</LastName><ForeName>Michelangelo</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-2738-8562</Identifier><AffiliationInfo><Affiliation>Neurological Institute, Department of Clinical and Experimental Medicine, University of Pisa, 56126 Pisa, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gragnaniello</LastName><ForeName>Daniela</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Nuerology Unit, Neurosciences and Rehabilitation Department, Ferrara University Hospital, 44124 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Granieri</LastName><ForeName>Enrico</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pugliatti</LastName><ForeName>Maura</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Unit of Clinical Neurology, Neurosciences and Rehabilitation Department, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Di Lorenzo</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Non Invasive Brain Stimulation Unit, Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia, 00179 Rome, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Giacomo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Non Invasive Brain Stimulation Unit, Istituto di Ricovero e Cura a Carattere Scientifico Santa Lucia, 00179 Rome, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Iit@Unife Center for Translational Neurophysiology, Istituto Italiano di Tecnologia, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Section of Human Physiology, Neurosciences and Rehabilitation Department, University of Ferrara, 44121 Ferrara, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D019636" MajorTopicYN="Y">Neurodegenerative Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020774" MajorTopicYN="Y">Pick Disease of the Brain</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013702" MajorTopicYN="N">Temporal Lobe</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">C9orf72</Keyword><Keyword MajorTopicYN="N">behavioural variant</Keyword><Keyword MajorTopicYN="N">biomarkers</Keyword><Keyword MajorTopicYN="N">frontotemporal dementia (FTD)</Keyword><Keyword MajorTopicYN="N">neurodegenerative dementias</Keyword><Keyword MajorTopicYN="N">non-Alzheimer&#x2019;s disease dementias</Keyword><Keyword MajorTopicYN="N">primary progressive aphasias</Keyword><Keyword MajorTopicYN="N">tau</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>7</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>19</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>7</Month><Day>31</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>11</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>29</Day><Hour>1</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37511491</ArticleId><ArticleId IdType="pmc">PMC10380352</ArticleId><ArticleId IdType="doi">10.3390/ijms241411732</ArticleId><ArticleId IdType="pii">ijms241411732</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Olney N.T., Spina S., Miller B.L. Frontotemporal Dementia. Neurol. Clin. 2017;35:339&#x2013;374. doi: 10.1016/j.ncl.2017.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2017.01.008</ArticleId><ArticleId IdType="pmc">PMC5472209</ArticleId><ArticleId IdType="pubmed">28410663</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam M.M., Wieneke C., Thompson C., Rogalski E., Weintraub S. Quantitative classification of primary progressive aphasia at early and mild impairment stages. Pt 5Brain. 2012;135:1537&#x2013;1553. doi: 10.1093/brain/aws080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws080</ArticleId><ArticleId IdType="pmc">PMC3577099</ArticleId><ArticleId IdType="pubmed">22525158</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A. Identification and Characterization of Frontal Lobe Degeneration: Historical perspective on the development of FTD. Alzheimer Dis. Assoc. Disord. 2007;21:S3&#x2013;S4. doi: 10.1097/WAD.0b013e31815bf511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e31815bf511</ArticleId><ArticleId IdType="pubmed">18090420</ArticleId></ArticleIdList></Reference><Reference><Citation>Logroscino G., Piccininni M., Graff C., Hardiman O., Ludolph A.C., Moreno F., Otto M., Remes A.M., Rowe J.B., Seelaar H., et al. Incidence of Syndromes Associated with Frontotemporal Lobar Degeneration in 9 European Countries. JAMA Neurol. 2023;80:279&#x2013;286. doi: 10.1001/jamaneurol.2022.5128.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2022.5128</ArticleId><ArticleId IdType="pmc">PMC9887528</ArticleId><ArticleId IdType="pubmed">36716024</ArticleId></ArticleIdList></Reference><Reference><Citation>Erkkinen M.G., Kim M.O., Geschwind M.D. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2018;10:a033118. doi: 10.1101/cshperspect.a033118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033118</ArticleId><ArticleId IdType="pmc">PMC5880171</ArticleId><ArticleId IdType="pubmed">28716886</ArticleId></ArticleIdList></Reference><Reference><Citation>Onyike C.U., Diehl-Schmid J. The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry. 2013;25:130&#x2013;137. doi: 10.3109/09540261.2013.776523.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.776523</ArticleId><ArticleId IdType="pmc">PMC3932112</ArticleId><ArticleId IdType="pubmed">23611343</ArticleId></ArticleIdList></Reference><Reference><Citation>Sosa-Ortiz A.L., Acosta-Castillo I., Prince M.J. Epidemiology of Dementias and Alzheimer&#x2019;s Disease. Arch. Med. Res. 2012;43:600&#x2013;608. doi: 10.1016/j.arcmed.2012.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2012.11.003</ArticleId><ArticleId IdType="pubmed">23159715</ArticleId></ArticleIdList></Reference><Reference><Citation>Coyle-Gilchrist I.T., Dick K.M., Patterson K., V&#xe1;zquez Rodr&#xed;quez P., Wehmann E., Wilcox A., Lansdall C.J., Dawson K.E., Wiggins J., Mead S., et al. Prevalence, characteristics, and survival of frontotemporal lobar degeneration syndromes. Neurology. 2016;86:1736&#x2013;1743. doi: 10.1212/WNL.0000000000002638.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000002638</ArticleId><ArticleId IdType="pmc">PMC4854589</ArticleId><ArticleId IdType="pubmed">27037234</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Kwong L.K., Truax A.C., Vanmassenhove B., Kretzschmar H.A., Van Deerlin V.M., Clark C.M., Grossman M., Miller B.L., Trojanowski J.Q., et al. TDP-43-Positive White Matter Pathology in Frontotemporal Lobar Degeneration With Ubiquitin-Positive Inclusions. J. Neuropathol. Exp. Neurol. 2007;66:177&#x2013;183. doi: 10.1097/01.jnen.0000248554.45456.58.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.jnen.0000248554.45456.58</ArticleId><ArticleId IdType="pubmed">17356379</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley W.W. Behavioral Variant Frontotemporal Dementia. Contin. Lifelong Learn. Neurol. 2019;25:76&#x2013;100. doi: 10.1212/CON.0000000000000698.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000698</ArticleId><ArticleId IdType="pubmed">30707188</ArticleId></ArticleIdList></Reference><Reference><Citation>Gazzina S., Manes M.A., Padovani A., Borroni B. Clinical and biological phenotypes of frontotemporal dementia: Perspectives for disease modifying therapies. Eur. J. Pharmacol. 2017;817:76&#x2013;85. doi: 10.1016/j.ejphar.2017.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejphar.2017.05.056</ArticleId><ArticleId IdType="pubmed">28579383</ArticleId></ArticleIdList></Reference><Reference><Citation>Piguet O., Kumfor F. Frontotemporal dementias: Main syndromes and underlying brain changes. Curr. Opin. Neurol. 2020;33:215&#x2013;221. doi: 10.1097/WCO.0000000000000792.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0000000000000792</ArticleId><ArticleId IdType="pubmed">32049742</ArticleId></ArticleIdList></Reference><Reference><Citation>Sheelakumari R., Bineesh C., Varghese T., Kesavadas C., Verghese J., Mathuranath P.S. Neuroanatomical correlates of apathy and disinhibition in behavioural variant frontotemporal dementia. Brain Imaging Behav. 2020;14:2004&#x2013;2011. doi: 10.1007/s11682-019-00150-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-019-00150-3</ArticleId><ArticleId IdType="pmc">PMC6942247</ArticleId><ArticleId IdType="pubmed">31273672</ArticleId></ArticleIdList></Reference><Reference><Citation>Warren J.D., Rohrer J.D., Rossor M.N. Frontotemporal dementia. BMJ. 2013;347:f4827. doi: 10.1136/bmj.f4827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.f4827</ArticleId><ArticleId IdType="pmc">PMC3735339</ArticleId><ArticleId IdType="pubmed">23920254</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges J.R., Piguet O. Progress and Challenges in Frontotemporal Dementia Research: A 20-Year Review. J. Alzheimer&#x2019;s Dis. 2018;62:1467&#x2013;1480. doi: 10.3233/JAD-171087.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-171087</ArticleId><ArticleId IdType="pmc">PMC5870022</ArticleId><ArticleId IdType="pubmed">29504536</ArticleId></ArticleIdList></Reference><Reference><Citation>Convery R., Mead S., Rohrer J.D. Review: Clinical, genetic and neuroimaging features of frontotemporal dementia. Neuropathol. Appl. Neurobiol. 2019;45:6&#x2013;18. doi: 10.1111/nan.12535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12535</ArticleId><ArticleId IdType="pubmed">30582889</ArticleId></ArticleIdList></Reference><Reference><Citation>Harciarek M., Cosentino S. Language, executive function and social cognition in the diagnosis of frontotemporal dementia syndromes. Int. Rev. Psychiatry. 2013;25:178&#x2013;196. doi: 10.3109/09540261.2013.763340.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.763340</ArticleId><ArticleId IdType="pmc">PMC4481322</ArticleId><ArticleId IdType="pubmed">23611348</ArticleId></ArticleIdList></Reference><Reference><Citation>Eslinger P.J., Moore P., Anderson C., Grossman M., Mendez M.F., Carr A.R., Jimenez E.E., Riedel B.C., Thompson P.M., Nowrangi M.A., et al. Social Cognition, Executive Functioning, and Neuroimaging Correlates of Empathic Deficits in Frontotemporal Dementia. J. Neuropsychiatry Clin. Neurosci. 2011;23:74&#x2013;82. doi: 10.1176/appi.neuropsych.23.1.74.</Citation><ArticleIdList><ArticleId IdType="doi">10.1176/appi.neuropsych.23.1.74</ArticleId><ArticleId IdType="pmc">PMC3641646</ArticleId><ArticleId IdType="pubmed">21304142</ArticleId></ArticleIdList></Reference><Reference><Citation>Gami-Patel P., van Dijken I., van Swieten J.C., Pijnenburg Y.A.L., Netherlands Brain Bank. Rozemuller A.J.M., Hoozemans J.J.M., Dijkstra A.A. Von Economo neurons are part of a larger neuronal population that are selectively vulnerable in C9orf72 frontotemporal dementia. Neuropathol. Appl. Neurobiol. 2019;45:671&#x2013;680. doi: 10.1111/nan.12558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12558</ArticleId><ArticleId IdType="pmc">PMC6915913</ArticleId><ArticleId IdType="pubmed">31066065</ArticleId></ArticleIdList></Reference><Reference><Citation>Iba&#xf1;ez A., Manes F. Contextual social cognition and the behavioral variant of frontotemporal dementia. Neurology. 2012;78:1354&#x2013;1362. doi: 10.1212/WNL.0b013e3182518375.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3182518375</ArticleId><ArticleId IdType="pmc">PMC3335455</ArticleId><ArticleId IdType="pubmed">22529204</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh S., Hornberger M., Piguet O., Hodges J.R. Neural basis of music knowledge: Evidence from the dementias. Pt 9Brain. 2011;134:2523&#x2013;2534. doi: 10.1093/brain/awr190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr190</ArticleId><ArticleId IdType="pubmed">21857031</ArticleId></ArticleIdList></Reference><Reference><Citation>Finger E.C. Frontotemporal Dementias. Contin. Lifelong Learn. Neurol. 2016;22:464&#x2013;489. doi: 10.1212/CON.0000000000000300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000300</ArticleId><ArticleId IdType="pmc">PMC5390934</ArticleId><ArticleId IdType="pubmed">27042904</ArticleId></ArticleIdList></Reference><Reference><Citation>Strong M.J., Abrahams S., Goldstein L.H., Woolley S., Mclaughlin P., Snowden J., Mioshi E., Roberts-South A., Benatar M., Hortob&#xe1;gyi T., et al. Amyotrophic lateral sclerosis&#x2014;Frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria. Amyotroph. Lateral Scler. Front. Degener. 2017;18:153&#x2013;174. doi: 10.1080/21678421.2016.1267768.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2016.1267768</ArticleId><ArticleId IdType="pmc">PMC7409990</ArticleId><ArticleId IdType="pubmed">28054827</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson J.C., Stopford C.L., Snowden J.S., Neary D. Qualitative neuropsychological performance characteristics in frontotemporal dementia and Alzheimer&#x2019;s disease. J. Neurol. Neurosurg. Psychiatry. 2005;76:920&#x2013;927. doi: 10.1136/jnnp.2003.033779.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2003.033779</ArticleId><ArticleId IdType="pmc">PMC1739700</ArticleId><ArticleId IdType="pubmed">15965196</ArticleId></ArticleIdList></Reference><Reference><Citation>Pennington C., Hodges J.R., Hornberger M. Neural Correlates of Episodic Memory in Behavioral Variant Frontotemporal Dementia. J. Alzheimer&#x2019;s Dis. 2011;24:261&#x2013;268. doi: 10.3233/JAD-2011-101668.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2011-101668</ArticleId><ArticleId IdType="pubmed">21239854</ArticleId></ArticleIdList></Reference><Reference><Citation>Rascovsky K., Hodges J.R., Knopman D., Mendez M.F., Kramer J.H., Neuhaus J., van Swieten J.C., Seelaar H., Dopper E.G., Onyike C.U., et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Pt 9Brain. 2011;134:2456&#x2013;2477. doi: 10.1093/brain/awr179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr179</ArticleId><ArticleId IdType="pmc">PMC3170532</ArticleId><ArticleId IdType="pubmed">21810890</ArticleId></ArticleIdList></Reference><Reference><Citation>Valverde A.H., Jimenez-Escrig A., Gobernado J., Bar&#xf3;n M. A short neuropsychologic and cognitive evaluation of frontotemporal dementia. Clin. Neurol. Neurosurg. 2009;111:251&#x2013;255. doi: 10.1016/j.clineuro.2008.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clineuro.2008.10.012</ArticleId><ArticleId IdType="pubmed">19062159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cosentino S., Chute D., Libon D., Moore P., Grossman M. How does the brain support script comprehension? A study of executive processes and semantic knowledge in dementia. Neuropsychology. 2006;20:307&#x2013;318. doi: 10.1037/0894-4105.20.3.307.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/0894-4105.20.3.307</ArticleId><ArticleId IdType="pubmed">16719624</ArticleId></ArticleIdList></Reference><Reference><Citation>Possin K., Chester S.K., Laluz V., Bostrom A., Rosen H., Miller B.L., Kramer J.K. The Frontal-Anatomic Specificity of Design Fluency Repetitions and Their Diagnostic Relevance for Behavioral Variant Frontotemporal Dementia. J. Int. Neuropsychol. Soc. 2012;18:834&#x2013;844. doi: 10.1017/S1355617712000604.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617712000604</ArticleId><ArticleId IdType="pmc">PMC3620020</ArticleId><ArticleId IdType="pubmed">22835330</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F., Piguet O. Disturbance of Emotion Processing in Frontotemporal Dementia: A Synthesis of Cognitive and Neuroimaging Findings. Neuropsychol. Rev. 2012;22:280&#x2013;297. doi: 10.1007/s11065-012-9201-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11065-012-9201-6</ArticleId><ArticleId IdType="pubmed">22577002</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F., Irish M., Hodges J.R., Piguet O. Discrete Neural Correlates for the Recognition of Negative Emotions: Insights from Frontotemporal Dementia. PLoS ONE. 2013;8:e67457. doi: 10.1371/journal.pone.0067457.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0067457</ArticleId><ArticleId IdType="pmc">PMC3689735</ArticleId><ArticleId IdType="pubmed">23805313</ArticleId></ArticleIdList></Reference><Reference><Citation>Bertoux M., Delavest M., de Souza L.C., Funkiewiez A., L&#xe9;pine J.P., Fossati P., Sarazin M. Social Cognition and Emotional Assessment differentiates frontotemporal dementia from depression. J. Neurol. Neurosurg. Psychiatry. 2011;83:411&#x2013;416. doi: 10.1136/jnnp-2011-301849.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301849</ArticleId><ArticleId IdType="pubmed">22291219</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald S., Flanagan S., Martin I., Saunders C. The ecological validity of TASIT: A test of social perception. Neuropsychol. Rehabil. 2014;14:285&#x2013;302. doi: 10.1080/09602010343000237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/09602010343000237</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F., Honan C., McDonald S., Hazelton J.L., Hodges J.R., Piguet O. Assessing the &#x201c;social brain&#x201d; in dementia: Applying TASIT-S. Cortex. 2017;93:166&#x2013;177. doi: 10.1016/j.cortex.2017.05.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2017.05.022</ArticleId><ArticleId IdType="pubmed">28662418</ArticleId></ArticleIdList></Reference><Reference><Citation>Hodges J.R., Mitchell J., Dawson K., Spillantini M.G., Xuereb J.H., McMonagle P., Nestor P.J., Patterson K. Semantic dementia: Demography, familial factors and survival in a consecutive series of 100 cases. Pt 1Brain. 2010;133:300&#x2013;306. doi: 10.1093/brain/awp248.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp248</ArticleId><ArticleId IdType="pubmed">19805492</ArticleId></ArticleIdList></Reference><Reference><Citation>Younes K., Miller B.L. Neuropsychiatric Aspects of Frontotemporal Dementia. Psychiatr. Clin. N. A. 2020;43:345&#x2013;360. doi: 10.1016/j.psc.2020.02.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psc.2020.02.005</ArticleId><ArticleId IdType="pubmed">32439026</ArticleId></ArticleIdList></Reference><Reference><Citation>Botha H., Josephs K.A. Primary Progressive Aphasias and Apraxia of Speech. Contin. Lifelong Learn. Neurol. 2019;25:101&#x2013;127. doi: 10.1212/CON.0000000000000699.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/CON.0000000000000699</ArticleId><ArticleId IdType="pmc">PMC6548538</ArticleId><ArticleId IdType="pubmed">30707189</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K.A., Whitwell J.L., Knopman D.S., Boeve B.F., Vemuri P., Senjem M.L., Parisi J.E., Ivnik R.J., Dickson D.W., Petersen R.C., Jr., et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009;73:1443&#x2013;1450. doi: 10.1212/WNL.0b013e3181bf9945.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bf9945</ArticleId><ArticleId IdType="pmc">PMC2779005</ArticleId><ArticleId IdType="pubmed">19884571</ArticleId></ArticleIdList></Reference><Reference><Citation>Bott N.T., Radke A., Stephens M.L., Kramer J.H. Frontotemporal dementia: Diagnosis, deficits and management. Neurodegener. Dis. Manag. 2014;4:439&#x2013;454. doi: 10.2217/nmt.14.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.2217/nmt.14.34</ArticleId><ArticleId IdType="pmc">PMC4824317</ArticleId><ArticleId IdType="pubmed">25531687</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabinovici G.D., Miller B.L. Frontotemporal Lobar Degeneration: Epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24:375&#x2013;398. doi: 10.2165/11533100-000000000-00000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2165/11533100-000000000-00000</ArticleId><ArticleId IdType="pmc">PMC2916644</ArticleId><ArticleId IdType="pubmed">20369906</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J.M., Saxon J.A., Jones M., Snowden J.S., Thompson J.C. Neuropsychological differentiation of progressive aphasic disorders. J. Neuropsychol. 2019;13:214&#x2013;239. doi: 10.1111/jnp.12149.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnp.12149</ArticleId><ArticleId IdType="pmc">PMC6618014</ArticleId><ArticleId IdType="pubmed">29424041</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam M., Rogalski E., Wieneke C., Cobia D., Rademaker A., Thompson C., Weintraub S. Neurology of anomia in the semantic variant of primary progressive aphasia. Pt 9Brain. 2009;132:2553&#x2013;2565. doi: 10.1093/brain/awp138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp138</ArticleId><ArticleId IdType="pmc">PMC2766179</ArticleId><ArticleId IdType="pubmed">19506067</ArticleId></ArticleIdList></Reference><Reference><Citation>Shim H., Hurley R.S., Rogalski E., Mesulam M.M. Anatomic, clinical, and neuropsychological correlates of spelling errors in primary progressive aphasia. Neuropsychologia. 2012;50:1929&#x2013;1935. doi: 10.1016/j.neuropsychologia.2012.04.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuropsychologia.2012.04.017</ArticleId><ArticleId IdType="pmc">PMC3527105</ArticleId><ArticleId IdType="pubmed">22579708</ArticleId></ArticleIdList></Reference><Reference><Citation>Butts A.M., Machulda M.M., Duffy J.R., Strand E.A., Whitwell J.L., Josephs K.A. Neuropsychological Profiles Differ among the Three Variants of Primary Progressive Aphasia. J. Int. Neuropsychol. Soc. 2015;21:429&#x2013;435. doi: 10.1017/S1355617715000399.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617715000399</ArticleId><ArticleId IdType="pmc">PMC6261353</ArticleId><ArticleId IdType="pubmed">26067425</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghosh S., Lippa C.F. Clinical Subtypes of Frontotemporal Dementia. Am. J. Alzheimer&#x2019;s Dis. Other Dementiasr. 2015;30:653&#x2013;661. doi: 10.1177/1533317513494442.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317513494442</ArticleId><ArticleId IdType="pubmed">23813692</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M. The non-fluent/agrammatic variant of primary progressive aphasia. Lancet Neurol. 2012;11:545&#x2013;555. doi: 10.1016/S1474-4422(12)70099-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(12)70099-6</ArticleId><ArticleId IdType="pmc">PMC3361730</ArticleId><ArticleId IdType="pubmed">22608668</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall C.R., Hardy C.J.D., Volkmer A., Russell L.L., Bond R.L., Fletcher P.D., Clark C.N., Mummery C.J., Schott J.M., Rossor M.N., et al. Primary progressive aphasia: A clinical approach. J. Neurol. 2018;265:1474&#x2013;1490. doi: 10.1007/s00415-018-8762-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-018-8762-6</ArticleId><ArticleId IdType="pmc">PMC5990560</ArticleId><ArticleId IdType="pubmed">29392464</ArticleId></ArticleIdList></Reference><Reference><Citation>Weintraub S., Mesulam M.M., Wieneke C., Rademaker A., Rogalski E.J., Thompson C.K. The Northwestern Anagram Test: Measuring Sentence Production in Primary Progressive Aphasia. Am. J. Alzheimer&#x2019;s Dis. Other Dementiasr. 2009;24:408&#x2013;416. doi: 10.1177/1533317509343104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1533317509343104</ArticleId><ArticleId IdType="pmc">PMC2836907</ArticleId><ArticleId IdType="pubmed">19700669</ArticleId></ArticleIdList></Reference><Reference><Citation>Graham N.L., Leonard C., Tang-Wai D.F., Black S., Chow T.W., Scott C.J., McNeely A.A., Masellis M., Rochon E. Lack of Frank Agrammatism in the Nonfluent Agrammatic Variant of Primary Progressive Aphasia. Dement. Geriatr. Cogn. Disord. Extra. 2016;6:407&#x2013;423. doi: 10.1159/000448944.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000448944</ArticleId><ArticleId IdType="pmc">PMC5075721</ArticleId><ArticleId IdType="pubmed">27790240</ArticleId></ArticleIdList></Reference><Reference><Citation>Knibb J.A., Woollams A.M., Hodges J.R., Patterson K. Making sense of progressive non-fluent aphasia: An analysis of conversational speech. Brain. 2009;132:2734&#x2013;2746. doi: 10.1093/brain/awp207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp207</ArticleId><ArticleId IdType="pmc">PMC2766235</ArticleId><ArticleId IdType="pubmed">19696033</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Rhun E., Richard F., Pasquier F. Natural history of primary progressive aphasia. Neurology. 2005;65:887&#x2013;891. doi: 10.1212/01.wnl.0000175982.57472.84.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000175982.57472.84</ArticleId><ArticleId IdType="pubmed">16186529</ArticleId></ArticleIdList></Reference><Reference><Citation>Armstrong M.J., Litvan I., Lang A.E., Bak T.H., Bhatia K.P., Borroni B., Boxer A.L., Dickson D.W., Grossman M., Hallett M., et al. Criteria for the diagnosis of corticobasal degeneration. Neurology. 2013;80:496&#x2013;503. doi: 10.1212/WNL.0b013e31827f0fd1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31827f0fd1</ArticleId><ArticleId IdType="pmc">PMC3590050</ArticleId><ArticleId IdType="pubmed">23359374</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosen H.J., Allison S.C., Ogar J.M., Amici S., Rose K., Dronkers N., Miller B.L., Gorno-Tempini M.L. Behavioral features in semantic dementia vs other forms of progressive aphasias. Neurology. 2006;67:1752&#x2013;1756. doi: 10.1212/01.wnl.0000247630.29222.34.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000247630.29222.34</ArticleId><ArticleId IdType="pubmed">17130406</ArticleId></ArticleIdList></Reference><Reference><Citation>Mesulam M.M., Grossman M., Hillis A., Kertesz A., Weintraub S. The core and halo of primary progressive aphasia and semantic dementia. Ann. Neurol. 2003;54((Suppl. S5)):S11&#x2013;S14. doi: 10.1002/ana.10569.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.10569</ArticleId><ArticleId IdType="pubmed">12833362</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell J.L., Weigand S.D., Duffy J.R., Clark H.M., Strand E.A., Machulda M.M., Spychalla A.J., Senjem M.L., Jack C.R., Jr., Josephs K.A. Predicting clinical decline in progressive agrammatic aphasia and apraxia of speech. Neurology. 2017;89:2271&#x2013;2279. doi: 10.1212/WNL.0000000000004685.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004685</ArticleId><ArticleId IdType="pmc">PMC5705252</ArticleId><ArticleId IdType="pubmed">29093069</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve B.F., Boxer A.L., Kumfor F., Pijnenburg Y., Rohrer J.D. Advances and controversies in frontotemporal dementia: Diagnosis, biomarkers, and therapeutic considerations. Lancet Neurol. 2022;21:258&#x2013;272. doi: 10.1016/S1474-4422(21)00341-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(21)00341-0</ArticleId><ArticleId IdType="pubmed">35182511</ArticleId></ArticleIdList></Reference><Reference><Citation>Teichmann M., Kas A., Boutet C., Ferrieux S., Nogues M., Samri D., Rogan C., Dormont D., Dubois B., Migliaccio R. Deciphering logopenic primary progressive aphasia: A clinical, imaging and biomarker investigation. Pt 11Brain. 2013;136:3474&#x2013;3488. doi: 10.1093/brain/awt266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awt266</ArticleId><ArticleId IdType="pubmed">24108322</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry M.L., Gorno-Tempini M.L. The logopenic variant of primary progressive aphasia. Curr. Opin. Neurol. 2010;23:633&#x2013;637. doi: 10.1097/WCO.0b013e32833fb93e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e32833fb93e</ArticleId><ArticleId IdType="pmc">PMC3201824</ArticleId><ArticleId IdType="pubmed">20852419</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Caso F., Mahoney C., Henry M., Rosen H.J., Rabinovici G., Rossor M.N., Miller B., Warren J.D., Fox N.C., et al. Patterns of longitudinal brain atrophy in the logopenic variant of primary progressive aphasia. Brain Lang. 2013;127:121&#x2013;126. doi: 10.1016/j.bandl.2012.12.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bandl.2012.12.008</ArticleId><ArticleId IdType="pmc">PMC3880853</ArticleId><ArticleId IdType="pubmed">23395096</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris J.M., Gall C., Thompson J.C., Richardson A.M., Neary D., du Plessis D., Pal P., Mann D.M., Snowden J.S., Jones M. Classification and pathology of primary progressive aphasia. Neurology. 2013;81:1832&#x2013;1839. doi: 10.1212/01.wnl.0000436070.28137.7b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000436070.28137.7b</ArticleId><ArticleId IdType="pubmed">24142474</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez-Caballero G., Abell&#xe1;n-Miralles I., S&#xe1;enz-Sanjuan M.J. Right temporal lobe variant of frontotemporal dementia. J. Clin. Neurosci. 2015;22:1139&#x2013;1143. doi: 10.1016/j.jocn.2014.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocn.2014.12.022</ArticleId><ArticleId IdType="pubmed">25981552</ArticleId></ArticleIdList></Reference><Reference><Citation>Okada A., Ohyama K., Ueda T. Early-stage right temporal lobe variant of frontotemporal dementia: 3 years of follow-up observations. BMJ Case Rep. 2018;29:bcr2018224431. doi: 10.1136/bcr-2018-224431.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bcr-2018-224431</ArticleId><ArticleId IdType="pmc">PMC6040506</ArticleId><ArticleId IdType="pubmed">29960960</ArticleId></ArticleIdList></Reference><Reference><Citation>Pozueta A., Lage C., Garc&#xed;a-Mart&#xed;nez M., Kazimierczak M., Bravo M., L&#xf3;pez-Garc&#xed;a S., Riancho J., Gonz&#xe1;lez-Suarez A., V&#xe1;zquez-Higuera J.L., de Arcocha-Torres M., et al. Cognitive and Behavioral Profiles of Left and Right Semantic Dementia: Differential Diagnosis with Behavioral Variant Frontotemporal Dementia and Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2019;72:1129&#x2013;1144. doi: 10.3233/JAD-190877.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-190877</ArticleId><ArticleId IdType="pubmed">31683488</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J.S., Harris J.M., Thompson J.C., Kobylecki C., Jones M., Richardson A.M., Neary D. Semantic dementia and the left and right temporal lobes. Cortex. 2018;107:188&#x2013;203. doi: 10.1016/j.cortex.2017.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2017.08.024</ArticleId><ArticleId IdType="pubmed">28947063</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan D., Anderson V., Pijnenburg Y., Whitwell J., Barnes J., Scahill R., Stevens J.M., Barkhof F., Scheltens P., Rossor M.N., et al. The clinical profile of right temporal lobe atrophy. Pt 5Brain. 2009;132:1287&#x2013;1298. doi: 10.1093/brain/awp037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp037</ArticleId><ArticleId IdType="pubmed">19297506</ArticleId></ArticleIdList></Reference><Reference><Citation>Veronelli L., Makaretz S.J., Quimby M., Dickerson B.C., Collins J.A. Geschwind Syndrome in frontotemporal lobar degeneration: Neuroanatomical and neuropsychological features over 9 years. Cortex. 2017;94:27&#x2013;38. doi: 10.1016/j.cortex.2017.06.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cortex.2017.06.003</ArticleId><ArticleId IdType="pmc">PMC5565695</ArticleId><ArticleId IdType="pubmed">28711815</ArticleId></ArticleIdList></Reference><Reference><Citation>Joubert S., Felician O., Barbeau E., Ranjeva J.-P., Christophe M., Didic M., Poncet M., Ceccaldi M. The right temporal lobe variant of frontotemporal dementia: Cognitive and neuroanatomical profile of three patients. J. Neurol. 2006;253:1447&#x2013;1458. doi: 10.1007/s00415-006-0232-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-006-0232-x</ArticleId><ArticleId IdType="pubmed">16773268</ArticleId></ArticleIdList></Reference><Reference><Citation>Kamminga J., Kumfor F., Burrell J.R., Piguet O., Hodges J.R., Irish M. Differentiating between right-lateralised semantic dementia and behavioural-variant frontotemporal dementia: An examination of clinical characteristics and emotion processing. J. Neurol. Neurosurg. Psychiatry. 2015;86:1082&#x2013;1088. doi: 10.1136/jnnp-2014-309120.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2014-309120</ArticleId><ArticleId IdType="pubmed">25511791</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghesani V., DeLeon J., Gorno-Tempini M.L. Frontotemporal dementia: A unique window on the functional role of the temporal lobes. Handb. Clin. Neurol. 2022;187:429&#x2013;448. doi: 10.1016/B978-0-12-823493-8.00011-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/B978-0-12-823493-8.00011-0</ArticleId><ArticleId IdType="pmc">PMC9793689</ArticleId><ArticleId IdType="pubmed">35964986</ArticleId></ArticleIdList></Reference><Reference><Citation>Possin K.L. Visual spatial cognition in neurodegenerative disease. Neurocase. 2010;16:466&#x2013;487. doi: 10.1080/13554791003730600.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13554791003730600</ArticleId><ArticleId IdType="pmc">PMC3028935</ArticleId><ArticleId IdType="pubmed">20526954</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornberger M., Piguet O. Episodic memory in frontotemporal dementia: A critical review. Pt 3Brain. 2012;135:678&#x2013;692. doi: 10.1093/brain/aws011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws011</ArticleId><ArticleId IdType="pubmed">22366790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumfor F., Landin-Romero R., Devenney E., Hutchings R., Grasso R., Hodges J.R., Piguet O. On the right side? A longitudinal study of left- versus right-lateralized semantic dementia. Pt 3Brain. 2016;139:986&#x2013;998. doi: 10.1093/brain/awv387.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv387</ArticleId><ArticleId IdType="pubmed">26811253</ArticleId></ArticleIdList></Reference><Reference><Citation>Fenoglio C., Scarpini E., Serpente M., Galimberti D. Role of Genetics and Epigenetics in the Pathogenesis of Alzheimer&#x2019;s Disease and Frontotemporal Dementia. J. Alzheimer&#x2019;s Dis. 2018;62:913&#x2013;932. doi: 10.3233/JAD-170702.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-170702</ArticleId><ArticleId IdType="pmc">PMC5870004</ArticleId><ArticleId IdType="pubmed">29562532</ArticleId></ArticleIdList></Reference><Reference><Citation>Greaves C.V., Rohrer J.D. An update on genetic frontotemporal dementia. J. Neurol. 2019;266:2075&#x2013;2086. doi: 10.1007/s00415-019-09363-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09363-4</ArticleId><ArticleId IdType="pmc">PMC6647117</ArticleId><ArticleId IdType="pubmed">31119452</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagner M., Lorenz G., Volk A.E., Brunet T., Edbauer D., Berutti R., Zhao C., Anderl-Straub S., Bertram L., Danek A., et al. Clinico-genetic findings in 509 frontotemporal dementia patients. Mol. Psychiatry. 2021;26:5824&#x2013;5832. doi: 10.1038/s41380-021-01271-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41380-021-01271-2</ArticleId><ArticleId IdType="pmc">PMC8758482</ArticleId><ArticleId IdType="pubmed">34561610</ArticleId></ArticleIdList></Reference><Reference><Citation>Borroni B., Bonvicini C., Galimberti D., Tremolizzo L., Papetti A., Archetti S., Turla M., Alberici A., Agosti C., Premi E., et al. Founder effect and estimation of the age of the Progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration. Neurobiol. Aging. 2011;32:555.e1&#x2013;555.e8. doi: 10.1016/j.neurobiolaging.2010.08.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2010.08.009</ArticleId><ArticleId IdType="pubmed">20947212</ArticleId></ArticleIdList></Reference><Reference><Citation>Barandiaran M., Estanga A., Moreno F., Indakoetxea B., Alzualde A., Balluerka N., Mart&#xed; Mass&#xf3; J.F., L&#xf3;pez de Munain A. Neuropsychological Features of Asymptomatic c.709-1G&gt;A Progranulin Mutation Carriers. J. Int. Neuropsychol. Soc. 2012;18:1086&#x2013;1090. doi: 10.1017/S1355617712000823.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S1355617712000823</ArticleId><ArticleId IdType="pubmed">23158232</ArticleId></ArticleIdList></Reference><Reference><Citation>Floris G., Borghero G., Cannas A., Di Stefano F., Murru M.R., Corongiu D., Cuccu S., Tranquilli S., Cherchi M.V., Serra A., et al. Clinical phenotypes and radiological findings in frontotemporal dementia related to TARDBP mutations. J. Neurol. 2015;262:375&#x2013;384. doi: 10.1007/s00415-014-7575-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-014-7575-5</ArticleId><ArticleId IdType="pubmed">25408367</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Neumann M. Molecular neuropathology of frontotemporal dementia: Insights into disease mechanisms from postmortem studies. J. Neurochem. 2016;138((Suppl. S1)):54&#x2013;70. doi: 10.1111/jnc.13588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.13588</ArticleId><ArticleId IdType="pubmed">27306735</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtishi A., Rosen B., Patil K.S., Alves G.W., M&#xf8;ller S.G. Cellular Proteostasis in Neurodegeneration. Mol. Neurobiol. 2019;56:3676&#x2013;3689. doi: 10.1007/s12035-018-1334-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1334-z</ArticleId><ArticleId IdType="pubmed">30182337</ArticleId></ArticleIdList></Reference><Reference><Citation>Balendra R., Isaacs A.M. C9orf72-mediated ALS and FTD: Multiple pathways to disease. Nat. Rev. Neurol. 2018;14:544&#x2013;558. doi: 10.1038/s41582-018-0047-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0047-2</ArticleId><ArticleId IdType="pmc">PMC6417666</ArticleId><ArticleId IdType="pubmed">30120348</ArticleId></ArticleIdList></Reference><Reference><Citation>Beckers J., Tharkeshwar A.K., Van Damme P. C9orf72 ALS-FTD: Recent evidence for dysregulation of the autophagy-lysosome pathway at multiple levels. Autophagy. 2021;17:3306&#x2013;3322. doi: 10.1080/15548627.2021.1872189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15548627.2021.1872189</ArticleId><ArticleId IdType="pmc">PMC8632097</ArticleId><ArticleId IdType="pubmed">33632058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lines G., Casey J.M., Preza E., Wray S. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. Mol. Cell. Neurosci. 2020;109:103553. doi: 10.1016/j.mcn.2020.103553.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2020.103553</ArticleId><ArticleId IdType="pubmed">32956830</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao J., Wang L., Yan T., Perry G., Wang X. TDP-43 proteinopathy and mitochondrial abnormalities in neurodegeneration. Mol. Cell. Neurosci. 2019;100:103396. doi: 10.1016/j.mcn.2019.103396.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2019.103396</ArticleId><ArticleId IdType="pmc">PMC6874890</ArticleId><ArticleId IdType="pubmed">31445085</ArticleId></ArticleIdList></Reference><Reference><Citation>Houghton O.H., Mizielinska S., Gomez-Suaga P. The Interplay Between Autophagy and RNA Homeostasis: Implications for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Cell Dev. Biol. 2022;10:838402. doi: 10.3389/fcell.2022.838402.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcell.2022.838402</ArticleId><ArticleId IdType="pmc">PMC9096704</ArticleId><ArticleId IdType="pubmed">35573690</ArticleId></ArticleIdList></Reference><Reference><Citation>Gomez-Suaga P., M&#xf3;rotz G.M., Markovinovic A., Mart&#xed;n-Guerrero S.M., Preza E., Arias N., Mayl K., Aabdien A., Gesheva V., Nishimura A., et al. Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. Aging Cell. 2022;21:e13549. doi: 10.1111/acel.13549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/acel.13549</ArticleId><ArticleId IdType="pmc">PMC8844122</ArticleId><ArticleId IdType="pubmed">35026048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch T., Sano M., Marder K.S., Bell K.L., Foster N.L., Defending R.F., Sima A.A., Keohane C., Nygaard T.G., Fahn S., et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia- parkinsonism-amyotrophy complex. Neurology. 1994;44:1878. doi: 10.1212/WNL.44.10.1878.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.44.10.1878</ArticleId><ArticleId IdType="pubmed">7936241</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Mandelkow E. Tau in physiology and pathology. Nat. Rev. Neurosci. 2016;17:22&#x2013;35. doi: 10.1038/nrn.2015.1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn.2015.1</ArticleId><ArticleId IdType="pubmed">26631930</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs G.G. Handbook of Clinical Neurology. Volume 145. Elsevier; Amsterdam, The Netherlands: 2017. Tauopathies; pp. 355&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/b978-0-12-802395-2.00025-0</ArticleId><ArticleId IdType="pubmed">28987182</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovelet-Lecrux A., Lecourtois M., Thomas-Anterion C., Le Ber I., Brice A., Frebourg T., Hannequin D., Campion D. Partial deletion of the MAPT gene: A novel mechanism of FTDP-17. Hum. Mutat. 2009;30:E591&#x2013;E602. doi: 10.1002/humu.20979.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/humu.20979</ArticleId><ArticleId IdType="pubmed">19263483</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovelet-Lecrux A., Hannequin D., Guillin O., Legallic S., Jurici S., Wallon D., Frebourg T., Campion D. Frontotemporal Dementia Phenotype Associated with MAPT Gene Duplication. J. Alzheimer&#x2019;s Dis. 2010;21:897&#x2013;902. doi: 10.3233/JAD-2010-100441.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-2010-100441</ArticleId><ArticleId IdType="pubmed">20634582</ArticleId></ArticleIdList></Reference><Reference><Citation>Waheed Z., Choudhary J., Jatala F.H., Fatimah, Noor A., Zerr I., Zafar S. The Role of Tau Proteoforms in Health and Disease. Mol. Neurobiol. 2023:1&#x2013;12. doi: 10.1007/s12035-023-03387-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-023-03387-8</ArticleId><ArticleId IdType="pubmed">37266762</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarko B., Hook V. Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration. Front. Neurosci. 2021;15:702788. doi: 10.3389/fnins.2021.702788.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.702788</ArticleId><ArticleId IdType="pmc">PMC8566764</ArticleId><ArticleId IdType="pubmed">34744602</ArticleId></ArticleIdList></Reference><Reference><Citation>Snowden J.S., Adams J., Harris J., Thompson J.C., Rollinson S., Richardson A., Jones M., Neary D., Mann D.M., Pickering-Brown S. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph. Lateral Scler. Front. Degener. 2015;16:497&#x2013;505. doi: 10.3109/21678421.2015.1074700.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1074700</ArticleId><ArticleId IdType="pubmed">26473392</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Epadovani A., Eborroni B. Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia. Front. Aging Neurosci. 2015;7:171. doi: 10.3389/fnagi.2015.00171.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2015.00171</ArticleId><ArticleId IdType="pmc">PMC4555036</ArticleId><ArticleId IdType="pubmed">26388768</ArticleId></ArticleIdList></Reference><Reference><Citation>Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442:920&#x2013;924. doi: 10.1038/nature05017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05017</ArticleId><ArticleId IdType="pubmed">16862115</ArticleId></ArticleIdList></Reference><Reference><Citation>Paushter D.H., Du H., Feng T., Hu F. The lysosomal function of progranulin, a guardian against neurodegeneration. Acta Neuropathol. 2018;136:1&#x2013;17. doi: 10.1007/s00401-018-1861-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1861-8</ArticleId><ArticleId IdType="pmc">PMC6117207</ArticleId><ArticleId IdType="pubmed">29744576</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu C.-E., Bird T.D., Bekris L.M., Montine T.J., Leverenz J.B., Steinbart E., Galloway N.M., Feldman H., Woltjer R., Miller C.A., et al. The Spectrum of Mutations in Progranulin: A collaborative study screening 545 cases of neurodegeneration. Arch. Neurol. 2010;67:161&#x2013;170. doi: 10.1001/archneurol.2009.328.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2009.328</ArticleId><ArticleId IdType="pmc">PMC2901991</ArticleId><ArticleId IdType="pubmed">20142524</ArticleId></ArticleIdList></Reference><Reference><Citation>Boland S., Swarup S., Ambaw Y.A., Malia P.C., Richards R.C., Fischer A.W., Singh S., Aggarwal G., Spina S., Nana A.L., et al. Deficiency of the frontotemporal dementia gene GRN results in gangliosidosis. Nat. Commun. 2022;13:5924. doi: 10.1038/s41467-022-33500-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-022-33500-9</ArticleId><ArticleId IdType="pmc">PMC9546883</ArticleId><ArticleId IdType="pubmed">36207292</ArticleId></ArticleIdList></Reference><Reference><Citation>Bright F., Werry E.L., Dobson-Stone C., Piguet O., Ittner L.M., Halliday G.M., Hodges J.R., Kiernan M.C., Loy C.T., Kassiou M., et al. Neuroinflammation in frontotemporal dementia. Nat. Rev. Neurol. 2019;15:540&#x2013;555. doi: 10.1038/s41582-019-0231-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0231-z</ArticleId><ArticleId IdType="pubmed">31324897</ArticleId></ArticleIdList></Reference><Reference><Citation>Renton A.E., Majounie E., Waite A., Sim&#xf3;n-Sa&#xe1;nchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD. Neuron. 2011;72:257&#x2013;268. doi: 10.1016/j.neuron.2011.09.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.09.010</ArticleId><ArticleId IdType="pmc">PMC3200438</ArticleId><ArticleId IdType="pubmed">21944779</ArticleId></ArticleIdList></Reference><Reference><Citation>Farg M.A., Sundaramoorthy V., Sultana J.M., Yang S., Atkinson R.A., Levina V., Halloran M.A., Gleeson P.A., Blair I.P., Soo K.Y., et al. C9ORF72, implicated in amytrophic lateral sclerosis and frontotemporal dementia, regulates endosomal trafficking. Hum. Mol. Genet. 2014;23:3579&#x2013;3595. doi: 10.1093/hmg/ddu068.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddu068</ArticleId><ArticleId IdType="pmc">PMC4049310</ArticleId><ArticleId IdType="pubmed">24549040</ArticleId></ArticleIdList></Reference><Reference><Citation>Shao W., Todd T.W., Wu Y., Jones C.Y., Tong J., Jansen-West K., Daughrity L.M., Park J., Koike Y., Kurti A., et al. Two FTD-ALS genes converge on the endosomal pathway to induce TDP-43 pathology and degeneration. Science. 2022;378:94&#x2013;99. doi: 10.1126/science.abq7860.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abq7860</ArticleId><ArticleId IdType="pmc">PMC9942492</ArticleId><ArticleId IdType="pubmed">36201573</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan B.K., Yokoyama J.S., Takada L.T., Sha S.J., Rutherford N.J., Fong J.C., Karydas A.M., Wu T., Ketelle R.S., Baker M.C., et al. Atypical, slowly progressive behavioural variant frontotemporal dementia associated with C9ORF72 hexanucleotide expansion. J. Neurol. Neurosurg. Psychiatry. 2012;83:358&#x2013;364. doi: 10.1136/jnnp-2011-301883.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2011-301883</ArticleId><ArticleId IdType="pmc">PMC3388906</ArticleId><ArticleId IdType="pubmed">22399793</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghetti B., Wszolek Z.K., Boeve B.F., Spina S., Goedert M. Neurodegeneration: The Molecular Pathology of Dementia and Movement Disorders. John Wiley &amp; Sons, Inc.; Hoboken, NJ, USA: 2011. Frontotemporal Dementia and Parkinsonism Linked to Chromosome 17; pp. 110&#x2013;134. Chapter 14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/9781444341256.ch14</ArticleId></ArticleIdList></Reference><Reference><Citation>Freischmidt A., Wieland T., Richter B., Ruf W., Schaeffer V., M&#xfc;ller K., Marroquin N., Nordin F., H&#xfc;bers A., Weydt P., et al. Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia. Nat. Neurosci. 2015;18:631&#x2013;636. doi: 10.1038/nn.4000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.4000</ArticleId><ArticleId IdType="pubmed">25803835</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Bieniek K.F., Finch N., van de Vorst M., Baker M., Perkersen R., Brown P., Ravenscroft T., van Blitterswijk M., Nicholson A.M., et al. Whole-genome sequencing reveals important role for TBK1 and OPTN mutations in frontotemporal lobar degeneration without motor neuron disease. Acta Neuropathol. 2015;130:77&#x2013;92. doi: 10.1007/s00401-015-1436-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-015-1436-x</ArticleId><ArticleId IdType="pmc">PMC4470809</ArticleId><ArticleId IdType="pubmed">25943890</ArticleId></ArticleIdList></Reference><Reference><Citation>Kovacs G.G., Murrell J.R., Horvath S., Haraszti L., Majtenyi K., Molnar M.J., Budka H., Ghetti B., Spina S. TARDBP variation associated with frontotemporal dementia, supranuclear gaze palsy, and chorea. Mov. Disord. 2009;24:1842&#x2013;1847. doi: 10.1002/mds.22697.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22697</ArticleId><ArticleId IdType="pubmed">19609911</ArticleId></ArticleIdList></Reference><Reference><Citation>Borghero G., Floris G., Cannas A., Marrosu M.G., Murru M.R., Costantino E., Parish L.D., Pugliatti M., Ticca A., Traynor B.J., et al. A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. Neurobiol. Aging. 2011;32:2327.e1&#x2013;2327.e5. doi: 10.1016/j.neurobiolaging.2011.06.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2011.06.009</ArticleId><ArticleId IdType="pmc">PMC3192246</ArticleId><ArticleId IdType="pubmed">21803454</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., Rademakers R., Roeber S., Baker M., Kretzschmar H.A., Mackenzie I.R. A new subtype of frontotemporal lobar degeneration with FUS pathology. Pt 11Brain. 2009;132:2922&#x2013;2931. doi: 10.1093/brain/awp214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awp214</ArticleId><ArticleId IdType="pmc">PMC2768659</ArticleId><ArticleId IdType="pubmed">19674978</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 2005;37:806&#x2013;808. doi: 10.1038/ng1609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1609</ArticleId><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Watts G.D., Thomasova D., Ramdeen S.K., Fulchiero E.C., Mehta S.G., Drachman D.A., Weihl C.C., Jamrozik Z., Kwiecinski H., Kaminska A., et al. Novel VCP mutations in inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia. Clin. Genet. 2007;72:420&#x2013;426. doi: 10.1111/j.1399-0004.2007.00887.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-0004.2007.00887.x</ArticleId><ArticleId IdType="pubmed">17935506</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson J.O., Mandrioli J., Benatar M., Abramzon Y., Van Deerlin V.M., Trojanowski J.Q., Gibbs J.R., Brunetti M., Gronka S., Wuu J., et al. Exome Sequencing Reveals VCP Mutations as a Cause of Familial ALS. Neuron. 2010;68:857&#x2013;864. doi: 10.1016/j.neuron.2010.11.036. Erratum in Neuron 2011, 69, 397.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2010.11.036</ArticleId><ArticleId IdType="pmc">PMC3032425</ArticleId><ArticleId IdType="pubmed">21145000</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Van Langenhove T., Kovacs G.G., Dillen L., Deschamps W., Engelborghs S., Mat&#x11b;j R., Vandenbulcke M., Sieben A., Dermaut B., et al. Rare mutations in SQSTM1 modify susceptibility to frontotemporal lobar degeneration. Acta Neuropathol. 2014;128:397&#x2013;410. doi: 10.1007/s00401-014-1298-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-014-1298-7</ArticleId><ArticleId IdType="pmc">PMC4131163</ArticleId><ArticleId IdType="pubmed">24899140</ArticleId></ArticleIdList></Reference><Reference><Citation>Bannwarth S., Ait-El-Mkadem S., Chaussenot A., Genin E.C., Lacas-Gervais S., Fragaki K., Berg-Alonso L., Kageyama Y., Serre V., Moore D.G., et al. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Pt 8Brain. 2014;137:2329&#x2013;2345. doi: 10.1093/brain/awu138.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu138</ArticleId><ArticleId IdType="pmc">PMC4107737</ArticleId><ArticleId IdType="pubmed">24934289</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature. 2011;477:211&#x2013;215. doi: 10.1038/nature10353.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature10353</ArticleId><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol M.O., Wong T.H., Melhem S., Basu S., Viscusi R., Galjart N., Rozemuller A.J.M., Fallini C., Landers J.E., Kaat L.D., et al. Novel TUBA4A Variant Associated with Familial Frontotemporal Dementia. Neurol. Genet. 2021;7:e596. doi: 10.1212/NXG.0000000000000596.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000596</ArticleId><ArticleId IdType="pmc">PMC8221227</ArticleId><ArticleId IdType="pubmed">34169147</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K.L., Topp S., Yang S., Smith B., Fifita J.A., Warraich S.T., Zhang K.Y., Farrawell N., Vance C., Hu X., et al. CCNF mutations in amyotrophic lateral sclerosis and frontotemporal dementia. Nat. Commun. 2016;7:11253. doi: 10.1038/ncomms11253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms11253</ArticleId><ArticleId IdType="pmc">PMC4835537</ArticleId><ArticleId IdType="pubmed">27080313</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie I.R., Nicholson A.M., Sarkar M., Messing J., Purice M.D., Pottier C., Annu K., Baker M., Perkerson R.B., Kurti A., et al. TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics. Neuron. 2017;95:808&#x2013;816.e9. doi: 10.1016/j.neuron.2017.07.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2017.07.025</ArticleId><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobson-Stone C., Hallupp M., Shahheydari H., Ragagnin A.M.G., Chatterton Z., Carew-Jones F., Shepherd C.E., Stefen H., Paric E., Fath T., et al. CYLD is a causative gene for frontotemporal dementia&#x2014;Amyotrophic lateral sclerosis. Brain. 2020;143:783&#x2013;799. doi: 10.1093/brain/awaa039.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa039</ArticleId><ArticleId IdType="pmc">PMC7089666</ArticleId><ArticleId IdType="pubmed">32185393</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Deerlin V.M., Sleiman P.M., Martinez-Lage M., Chen-Plotkin A., Wang L.S., Graff-Radford N.R., Dickson D.W., Rademakers R., Boeve B.F., Grossman M., et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 2010;42:234&#x2013;239. doi: 10.1038/ng.536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.536</ArticleId><ArticleId IdType="pmc">PMC2828525</ArticleId><ArticleId IdType="pubmed">20154673</ArticleId></ArticleIdList></Reference><Reference><Citation>Finch N., Carrasquillo M.M., Baker M., Rutherford N.J., Coppola G., DeJesus-Hernandez M., Crook R., Hunter T., Ghidoni R., Benussi L., et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology. 2011;76:467&#x2013;474. doi: 10.1212/WNL.0b013e31820a0e3b.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31820a0e3b</ArticleId><ArticleId IdType="pmc">PMC3034409</ArticleId><ArticleId IdType="pubmed">21178100</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrari R., Hernandez D.G., Nalls M.A., Rohrer J.D., Ramasamy A., Kwok J.B., Dobson-Stone C., Brooks W.S., Schofield P.R., Halliday G.M., et al. Frontotemporal dementia and its subtypes: A genome-wide association study. Lancet Neurol. 2014;13:686&#x2013;699. doi: 10.1016/S1474-4422(14)70065-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70065-1</ArticleId><ArticleId IdType="pmc">PMC4112126</ArticleId><ArticleId IdType="pubmed">24943344</ArticleId></ArticleIdList></Reference><Reference><Citation>Pottier C., Zhou X., Perkerson R.B., 3rd, Baker M., Jenkins G.D., Serie D.J., Ghidoni R., Benussi L., Binetti G., L&#xf3;pez de Munain A., et al. Potential genetic modifiers of disease risk and age at onset in patients with frontotemporal lobar degeneration and GRN mutations: A genome-wide association study. Lancet Neurol. 2018;17:548&#x2013;558. doi: 10.1016/S1474-4422(18)30126-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30126-1</ArticleId><ArticleId IdType="pmc">PMC6237181</ArticleId><ArticleId IdType="pubmed">29724592</ArticleId></ArticleIdList></Reference><Reference><Citation>Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch. Gerontol. Geriatr. 1987;6:193&#x2013;208. doi: 10.1016/0167-4943(87)90021-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0167-4943(87)90021-5</ArticleId><ArticleId IdType="pubmed">3689053</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones D.T., Knopman D.S., Graff-Radford J., Syrjanen J.A., Senjem M.L., Schwarz C.G., Dheel C., Wszolek Z., Rademakers R., Kantarci K., et al. In vivo 18F-AV-1451 tau PET signal in MAPT mutation carriers varies by expected tau isoforms. Neurology. 2018;90:e947&#x2013;e954. doi: 10.1212/WNL.0000000000005117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005117</ArticleId><ArticleId IdType="pmc">PMC5858948</ArticleId><ArticleId IdType="pubmed">29440563</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M., MacKenzie I.R.A. Review: Neuropathology of non-tau frontotemporal lobar degeneration. Neuropathol. Appl. Neurobiol. 2019;45:19&#x2013;40. doi: 10.1111/nan.12526.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12526</ArticleId><ArticleId IdType="pubmed">30357887</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry D.C., Brown J.A., Possin K.L., Datta S., Trujillo A., Radke A., Karydas A., Kornak J., Sias A.C., Rabinovici G.D., et al. Clinicopathological correlations in behavioural variant frontotemporal dementia. Brain. 2017;140:3329&#x2013;3345. doi: 10.1093/brain/awx254.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx254</ArticleId><ArticleId IdType="pmc">PMC5841140</ArticleId><ArticleId IdType="pubmed">29053860</ArticleId></ArticleIdList></Reference><Reference><Citation>Seeley W.W., Crawford R., Rascovsky K., Kramer J.H., Weiner M., Miller B.L., Gorno-Tempini M.L. Frontal Paralimbic Network Atrophy in Very Mild Behavioral Variant Frontotemporal Dementia. Arch. Neurol. 2008;65:249&#x2013;255. doi: 10.1001/archneurol.2007.38.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2007.38</ArticleId><ArticleId IdType="pmc">PMC2544627</ArticleId><ArticleId IdType="pubmed">18268196</ArticleId></ArticleIdList></Reference><Reference><Citation>Molnar-Szakacs I., Uddin L.Q. Anterior insula as a gatekeeper of executive control. Neurosci. Biobehav. Rev. 2022;139:104736. doi: 10.1016/j.neubiorev.2022.104736.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2022.104736</ArticleId><ArticleId IdType="pubmed">35700753</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitwell J.L., Jack C.R., Jr., Boeve B.F., Senjem M.L., Baker M., Ivnik R.J., Knopman D.S., Wszolek Z.K., Petersen R.C., Rademakers R., et al. Atrophy patterns in IVS10+16, IVS10+3, N279K, S305N, P301L, and V337M MAPT mutations. Neurology. 2009;73:1058&#x2013;1065. doi: 10.1212/WNL.0b013e3181b9c8b9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181b9c8b9</ArticleId><ArticleId IdType="pmc">PMC2754325</ArticleId><ArticleId IdType="pubmed">19786698</ArticleId></ArticleIdList></Reference><Reference><Citation>Beck J., Rohrer J.D., Campbell T., Isaacs A., Morrison K.E., Goodall E.F., Warrington E.K., Stevens J., Revesz T., Holton J., et al. A distinct clinical, neuropsychological and radiological phenotype is associated with progranulin gene mutations in a large UK series. Pt 3Brain. 2008;131:706&#x2013;720. doi: 10.1093/brain/awm320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awm320</ArticleId><ArticleId IdType="pmc">PMC2577762</ArticleId><ArticleId IdType="pubmed">18234697</ArticleId></ArticleIdList></Reference><Reference><Citation>Perry D.C., Lehmann M., Yokoyama J.S., Karydas A., Lee J.J., Coppola G., Grinberg L.T., Geschwind D., Seeley W.W., Miller B.L., et al. Progranulin Mutations as Risk Factors for Alzheimer Disease. JAMA Neurol. 2013;70:774&#x2013;778. doi: 10.1001/2013.jamaneurol.393.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/2013.jamaneurol.393</ArticleId><ArticleId IdType="pmc">PMC3743672</ArticleId><ArticleId IdType="pubmed">23609919</ArticleId></ArticleIdList></Reference><Reference><Citation>Boeve B.F., Boylan K.B., Graff-Radford N.R., DeJesus-Hernandez M., Knopman D.S., Pedraza O., Vemuri P., Jones D., Lowe V., Murray M.E., et al. Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Pt 3Brain. 2012;135:765&#x2013;783. doi: 10.1093/brain/aws004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/aws004</ArticleId><ArticleId IdType="pmc">PMC3286335</ArticleId><ArticleId IdType="pubmed">22366793</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahoney C.J., Beck J., Rohrer J.D., Lashley T., Mok K., Shakespeare T., Yeatman T., Warrington E.K., Schott J.M., Fox N.C., et al. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: Clinical, neuroanatomical and neuropathological features. Pt 3Brain. 2012;135:736&#x2013;750. doi: 10.1093/brain/awr361.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr361</ArticleId><ArticleId IdType="pmc">PMC3286330</ArticleId><ArticleId IdType="pubmed">22366791</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan R.H., Wong S., Kril J.J., Piguet O., Hornberger M., Hodges J.R., Halliday G.M. Beyond the temporal pole: Limbic memory circuit in the semantic variant of primary progressive aphasia. Pt 7Brain. 2014;137:2065&#x2013;2076. doi: 10.1093/brain/awu118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awu118</ArticleId><ArticleId IdType="pubmed">24844729</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinelli E.G., Mandelli M.L., Miller Z.A., Santos-Santos M.A., Wilson S.M., Agosta F., Grinberg L.T., Huang E.J., Trojanowski J.Q., Meyer M., et al. Typical and atypical pathology in primary progressive aphasia variants. Ann. Neurol. 2017;81:430&#x2013;443. doi: 10.1002/ana.24885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24885</ArticleId><ArticleId IdType="pmc">PMC5421819</ArticleId><ArticleId IdType="pubmed">28133816</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E., van der Zee J., Turon Estrada A., Van Broeckhoven C., Sanchez-Valle R. TARDBP mutation p.Ile383Val associated with semantic dementia and complex proteinopathy. Neuropathol. Appl. Neurobiol. 2014;40:225&#x2013;230. doi: 10.1111/nan.12063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12063</ArticleId><ArticleId IdType="pubmed">23692129</ArticleId></ArticleIdList></Reference><Reference><Citation>Chare L., Hodges J.R., Leyton C.E., McGinley C., Tan R.H., Kril J.J., Halliday G.M. New criteria for frontotemporal dementia syndromes: Clinical and pathological diagnostic implications. J. Neurol. Neurosurg. Psychiatry. 2014;85:865&#x2013;870. doi: 10.1136/jnnp-2013-306948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2013-306948</ArticleId><ArticleId IdType="pubmed">24421286</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K.A., Hodges J.R., Snowden J.S., Mackenzie I.R., Neumann M., Mann D.M., Dickson D.W. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122:137&#x2013;153. doi: 10.1007/s00401-011-0839-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0839-6</ArticleId><ArticleId IdType="pmc">PMC3232515</ArticleId><ArticleId IdType="pubmed">21614463</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulugut H., Dijkstra A.A., Scarioni M., Netherlands Brain Bank. Barkhof F., Scheltens P., Rozemuller A.J.M., Pijnenburg Y.A.L. Right temporal variant frontotemporal dementia is pathologically heterogeneous: A case-series and a systematic review. Acta Neuropathol. Commun. 2021;9:131. doi: 10.1186/s40478-021-01229-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-021-01229-z</ArticleId><ArticleId IdType="pmc">PMC8330072</ArticleId><ArticleId IdType="pubmed">34344452</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Lashley T., Schott J.M., Warren J.E., Mead S., Isaacs A.M., Beck J., Hardy J., de Silva R., Warrington E., et al. Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Pt 9Brain. 2011;134:2565&#x2013;2581. doi: 10.1093/brain/awr198.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr198</ArticleId><ArticleId IdType="pmc">PMC3170537</ArticleId><ArticleId IdType="pubmed">21908872</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee E.B., Porta S., Michael Baer G., Xu Y., Suh E., Kwong L.K., Elman L., Grossman M., Lee V.M., Irwin D.J., et al. Expansion of the classification of FTLD-TDP: Distinct pathology associated with rapidly progressive frontotemporal degeneration. Acta Neuropathol. 2017;134:65&#x2013;78. doi: 10.1007/s00401-017-1679-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-017-1679-9</ArticleId><ArticleId IdType="pmc">PMC5521959</ArticleId><ArticleId IdType="pubmed">28130640</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulugut Erkoyun H., Groot C., Heilbron R., Nelissen A., van Rossum J., Jutten R., Koene T., van der Flier W.M., Wattjes M.P., Scheltens P., et al. A clinical-radiological framework of the right temporal variant of frontotemporal dementia. Brain. 2020;143:2831&#x2013;2843. doi: 10.1093/brain/awaa225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa225</ArticleId><ArticleId IdType="pmc">PMC9172625</ArticleId><ArticleId IdType="pubmed">32830218</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorno-Tempini M.L., Hillis A.E., Weintraub S., Kertesz A., Mendez M., Cappa S.F., Ogar J.M., Rohrer J.D., Black S., Boeve B.F., et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76:1006&#x2013;1014. doi: 10.1212/WNL.0b013e31821103e6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e31821103e6</ArticleId><ArticleId IdType="pmc">PMC3059138</ArticleId><ArticleId IdType="pubmed">21325651</ArticleId></ArticleIdList></Reference><Reference><Citation>Tahmasian M., Shao J., Meng C., Grimmer T., Diehl-Schmid J., Yousefi B.H., F&#xf6;rster S., Riedl V., Drzezga A., Sorg C. Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study. J. Nucl. Med. 2016;57:410&#x2013;415. doi: 10.2967/jnumed.115.165464.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.115.165464</ArticleId><ArticleId IdType="pubmed">26585059</ArticleId></ArticleIdList></Reference><Reference><Citation>Vijverberg E.G., Wattjes M.P., Dols A., Krudop W.A., M&#xf6;ller C., Peters A., Kerssens C.J., Gossink F., Prins N.D., Stek M.L., et al. Diagnostic Accuracy of MRI and Additional [18F]FDG-PET for Behavioral Variant Frontotemporal Dementia in Patients with Late Onset Behavioral Changes. J. Alzheimer&#x2019;s Dis. 2016;53:1287&#x2013;1297. doi: 10.3233/JAD-160285.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-160285</ArticleId><ArticleId IdType="pubmed">27372646</ArticleId></ArticleIdList></Reference><Reference><Citation>Bejanin A., Tammewar G., Marx G., Cobigo Y., Iaccarino L., Kornak J., Staffaroni A.M., Dickerson B.C., Boeve B.F., Knopman D.S., et al. Longitudinal structural and metabolic changes in frontotemporal dementia. Neurology. 2020;95:e140&#x2013;e154. doi: 10.1212/WNL.0000000000009760.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000009760</ArticleId><ArticleId IdType="pmc">PMC7455324</ArticleId><ArticleId IdType="pubmed">32591470</ArticleId></ArticleIdList></Reference><Reference><Citation>Narayanan L., Murray A.D. What can imaging tell us about cognitive impairment and dementia? World J. Radiol. 2016;8:240&#x2013;254. doi: 10.4329/wjr.v8.i3.240.</Citation><ArticleIdList><ArticleId IdType="doi">10.4329/wjr.v8.i3.240</ArticleId><ArticleId IdType="pmc">PMC4807333</ArticleId><ArticleId IdType="pubmed">27029053</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xf6;ller C., Hafkemeijer A., Pijnenburg Y.A., Rombouts S.A., van der Grond J., Dopper E., van Swieten J., Versteeg A., Pouwels P.J., Barkhof F., et al. Joint assessment of white matter integrity, cortical and subcortical atrophy to distinguish AD from behavioral variant FTD: A two-center study. NeuroImage Clin. 2015;9:418&#x2013;429. doi: 10.1016/j.nicl.2015.08.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nicl.2015.08.022</ArticleId><ArticleId IdType="pmc">PMC4600847</ArticleId><ArticleId IdType="pubmed">26594624</ArticleId></ArticleIdList></Reference><Reference><Citation>Filippi M., Basaia S., Canu E., Imperiale F., Meani A., Caso F., Magnani G., Falautano M., Comi G., Falini A., et al. Brain network connectivity differs in early-onset neurodegenerative dementia. Neurology. 2017;89:1764&#x2013;1772. doi: 10.1212/WNL.0000000000004577.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004577</ArticleId><ArticleId IdType="pmc">PMC5664301</ArticleId><ArticleId IdType="pubmed">28954876</ArticleId></ArticleIdList></Reference><Reference><Citation>Buhour M.-S., Doidy F., Laisney M., Pitel A.L., de La Sayette V., Viader F., Eustache F., Desgranges B. Pathophysiology of the behavioral variant of frontotemporal lobar degeneration: A study combining MRI and FDG-PET. Brain Imaging Behav. 2017;11:240&#x2013;252. doi: 10.1007/s11682-016-9521-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11682-016-9521-x</ArticleId><ArticleId IdType="pubmed">26852326</ArticleId></ArticleIdList></Reference><Reference><Citation>Ducharme S., Dols A., Laforce R., Devenney E., Kumfor F., van den Stock J., Dallaire-Th&#xe9;roux C., Seelaar H., Gossink F., Vijverberg E., et al. Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders. Brain. 2020;143:1632&#x2013;1650. doi: 10.1093/brain/awaa018. Erratum in Brain 2020, 143, e62.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa018</ArticleId><ArticleId IdType="pmc">PMC7849953</ArticleId><ArticleId IdType="pubmed">32129844</ArticleId></ArticleIdList></Reference><Reference><Citation>Josephs K.A., Martin P.R., Botha H., Schwarz C.G., Duffy J.R., Clark H.M., Machulda M.M., Graff- Radford J., Weigand S.D., Senjem M.L., et al. [18 F]AV-1451 tau-PET and primary progressive aphasia. Ann. Neurol. 2018;83:599&#x2013;611. doi: 10.1002/ana.25183.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.25183</ArticleId><ArticleId IdType="pmc">PMC5896771</ArticleId><ArticleId IdType="pubmed">29451323</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Guerreiro R., Vandrovcova J., Uphill J., Reiman D., Beck J., Isaacs A.M., Authier A., Ferrari R., Fox N.C., et al. The heritability and genetics of frontotemporal lobar degeneration. Neurology. 2009;73:1451&#x2013;1456. doi: 10.1212/WNL.0b013e3181bf997a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0b013e3181bf997a</ArticleId><ArticleId IdType="pmc">PMC2779007</ArticleId><ArticleId IdType="pubmed">19884572</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore K.M., Nicholas J., Grossman M., McMillan C.T., Irwin D.J., Massimo L., Van Deerlin V.M., Warren J.D., Fox N.C., Rossor M.N., et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: An international retrospective cohort study. Lancet Neurol. 2020;19:145&#x2013;156. doi: 10.1016/S1474-4422(19)30394-1. Erratum in Lancet Neurol. 2020, 19, e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(19)30394-1</ArticleId><ArticleId IdType="pmc">PMC7007771</ArticleId><ArticleId IdType="pubmed">31810826</ArticleId></ArticleIdList></Reference><Reference><Citation>Rohrer J.D., Nicholas J.M., Cash D.M., van Swieten J., Dopper E., Jiskoot L., van Minkelen R., Rombouts S.A., Cardoso M.J., Clegg S., et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: A cross-sectional analysis. Lancet Neurol. 2015;14:253&#x2013;262. doi: 10.1016/S1474-4422(14)70324-2. Erratum in Lancet Neurol. 2015, 14, 1151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(14)70324-2</ArticleId><ArticleId IdType="pmc">PMC6742501</ArticleId><ArticleId IdType="pubmed">25662776</ArticleId></ArticleIdList></Reference><Reference><Citation>Panman J.L., Jiskoot L.C., Bouts M.J.R.J., Meeter L.H.H., van der Ende E.L., Poos J.M., Feis R.A., Kievit A.J.A., Van Minkelen R., Dopper E.G., et al. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: A longitudinal MRI study. Neurobiol. Aging. 2019;76:115&#x2013;124. doi: 10.1016/j.neurobiolaging.2018.12.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2018.12.017</ArticleId><ArticleId IdType="pubmed">30711674</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H., Van Swieten J.C., Boxer A.L., Rohrer J.D. Review: Fluid biomarkers for frontotemporal dementias. Neuropathol. Appl. Neurobiol. 2019;45:81&#x2013;87. doi: 10.1111/nan.12530.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/nan.12530</ArticleId><ArticleId IdType="pubmed">30422329</ArticleId></ArticleIdList></Reference><Reference><Citation>Doroszkiewicz J., Groblewska M., Mroczko B. Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases. Int. J. Mol. Sci. 2022;23:4610. doi: 10.3390/ijms23094610.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms23094610</ArticleId><ArticleId IdType="pmc">PMC9100918</ArticleId><ArticleId IdType="pubmed">35563001</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura T., Fujita K., Kawakami S., Takeda K., Chan S., Beligere G., Dowell B. Stability of Pro-Gastrin-Releasing Peptide in Serum versus Plasma. Tumor Biol. 2008;29:224&#x2013;230. doi: 10.1159/000152940.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000152940</ArticleId><ArticleId IdType="pubmed">18781094</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolstad N., Warren D.J., Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract. Res. Clin. Endocrinol. Metab. 2013;27:647&#x2013;661. doi: 10.1016/j.beem.2013.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2013.05.011</ArticleId><ArticleId IdType="pubmed">24094636</ArticleId></ArticleIdList></Reference><Reference><Citation>Apweiler R., Aslanidis C., Deufel T., Gerstner A., Hansen J., Hochstrasser D., Kellner R., Kubicek M., Lottspeich F., Maser E., et al. Approaching clinical proteomics: Current state and future fields of application in fluid proteomics. Clin. Chem. Lab. Med. 2009;47:724&#x2013;744. doi: 10.1515/CCLM.2009.167.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/CCLM.2009.167</ArticleId><ArticleId IdType="pubmed">19527139</ArticleId></ArticleIdList></Reference><Reference><Citation>Zetterberg H., Blennow K. From Cerebrospinal Fluid to Blood: The Third Wave of Fluid Biomarkers for Alzheimer&#x2019;s Disease. J. Alzheimer&#x2019;s Dis. 2018;64:S271&#x2013;S279. doi: 10.3233/JAD-179926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-179926</ArticleId><ArticleId IdType="pubmed">29758941</ArticleId></ArticleIdList></Reference><Reference><Citation>Verde F., Otto M., Silani V. Neurofilament Light Chain as Biomarker for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Front. Neurosci. 2021;15 doi: 10.3389/fnins.2021.679199.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2021.679199</ArticleId><ArticleId IdType="pmc">PMC8255624</ArticleId><ArticleId IdType="pubmed">34234641</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Rao M.V., Veeranna, Nixon R.A. Neurofilaments and Neurofilament Proteins in Health and Disease. Cold Spring Harb. Perspect. Biol. 2017;9:a018309. doi: 10.1101/cshperspect.a018309.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a018309</ArticleId><ArticleId IdType="pmc">PMC5378049</ArticleId><ArticleId IdType="pubmed">28373358</ArticleId></ArticleIdList></Reference><Reference><Citation>Barry D.M., Stevenson W., Bober B.G., Wiese P.J., Dale J.M., Barry G.S., Byers N.S., Strope J.D., Chang R., Schulz D.J., et al. Expansion of Neurofilament Medium C Terminus Increases Axonal Diameter Independent of Increases in Conduction Velocity or Myelin Thickness. J. Neurosci. 2012;32:6209&#x2013;6219. doi: 10.1523/JNEUROSCI.0647-12.2012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.0647-12.2012</ArticleId><ArticleId IdType="pmc">PMC3363292</ArticleId><ArticleId IdType="pubmed">22553027</ArticleId></ArticleIdList></Reference><Reference><Citation>Gentil B.J., Tibshirani M., Durham H.D. Neurofilament dynamics and involvement in neurological disorders. Cell Tissue Res. 2015;360:609&#x2013;620. doi: 10.1007/s00441-014-2082-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00441-014-2082-7</ArticleId><ArticleId IdType="pubmed">25567110</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocquet A., Berges R., Frank R., Robert P., Peterson A.C., Eyer J. Neurofilaments Bind Tubulin and Modulate Its Polymerization. J. Neurosci. 2009;29:11043&#x2013;11054. doi: 10.1523/JNEUROSCI.1924-09.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1924-09.2009</ArticleId><ArticleId IdType="pmc">PMC6665525</ArticleId><ArticleId IdType="pubmed">19726663</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Veeranna, Sershen H., Basavarajappa B.S., Smiley J.F., Hashim A., Bleiwas C., Berg M., Guifoyle D.N., Subbanna S., et al. Neurofilament light interaction with GluN1 modulates neurotransmission and schizophrenia-associated behaviors. Transl. Psychiatry. 2018;8:167. doi: 10.1038/s41398-018-0194-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41398-018-0194-7</ArticleId><ArticleId IdType="pmc">PMC6109052</ArticleId><ArticleId IdType="pubmed">30143609</ArticleId></ArticleIdList></Reference><Reference><Citation>Khalil M., Teunissen C.E., Otto M., Piehl F., Sormani M.P., Gattringer T., Barro C., Kappos L., Comabella M., Fazekas F., et al. Neurofilaments as biomarkers in neurological disorders. Nat. Rev. Neurol. 2018;14:577&#x2013;589. doi: 10.1038/s41582-018-0058-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-018-0058-z</ArticleId><ArticleId IdType="pubmed">30171200</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaetani L., Blennow K., Calabresi P., Di Filippo M., Parnetti L., Zetterberg H. Neurofilament light chain as a biomarker in neurological disorders. J. Neurol. Neurosurg. Psychiatry. 2019;90:870&#x2013;881. doi: 10.1136/jnnp-2018-320106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320106</ArticleId><ArticleId IdType="pubmed">30967444</ArticleId></ArticleIdList></Reference><Reference><Citation>Niikado M., Chrem-M&#xe9;ndez P., Itzcovich T., Barbieri-Kennedy M., Calandri I., Martinetto H., Serra M., Calvar J., Campos J., Russo M.J., et al. Evaluation of Cerebrospinal Fluid Neurofilament Light Chain as a Routine Biomarker in a Memory Clinic. J. Gerontol. A Biol. Sci. Med. Sci. 2019;74:442&#x2013;445. doi: 10.1093/gerona/gly179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/gly179</ArticleId><ArticleId IdType="pubmed">30107413</ArticleId></ArticleIdList></Reference><Reference><Citation>Skillb&#xe4;ck T., Mattsson N., Blennow K., Zetterberg H. Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival. Amyotroph. Lateral Scler. Front. Degener. 2017;18:397&#x2013;403. doi: 10.1080/21678421.2017.1281962.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/21678421.2017.1281962</ArticleId><ArticleId IdType="pubmed">28631955</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljungqvist J., Zetterberg H., Mitsis M., Blennow K., Skoglund T., Wirsching A., Chen Z., Bevilacqua Z.W., Huibregtse M.E., Kawata K., et al. Serum Neurofilament Light Protein as a Marker for Diffuse Axonal Injury: Results from a Case Series Study. J. Neurotrauma. 2017;34:1124&#x2013;1127. doi: 10.1089/neu.2016.4496.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/neu.2016.4496</ArticleId><ArticleId IdType="pubmed">27539721</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeter L.H., Dopper E.G., Jiskoot L.C., Sanchez-Valle R., Graff C., Benussi L., Ghidoni R., Pijnenburg Y.A., Borroni B., Galimberti D., et al. Neurofilament light chain: A biomarker for genetic frontotemporal dementia. Ann. Clin. Transl. Neurol. 2016;3:623&#x2013;636. doi: 10.1002/acn3.325.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.325</ArticleId><ArticleId IdType="pmc">PMC4999594</ArticleId><ArticleId IdType="pubmed">27606344</ArticleId></ArticleIdList></Reference><Reference><Citation>Scherling C.S., Hall T., Berisha F., Klepac K., Karydas A., Coppola G., Kramer J.H., Rabinovici G., Ahlijanian M., Miller B.L., et al. Cerebrospinal fluid neurofilament concentration reflects disease severity in frontotemporal degeneration. Ann. Neurol. 2014;75:116&#x2013;126. doi: 10.1002/ana.24052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24052</ArticleId><ArticleId IdType="pmc">PMC4020786</ArticleId><ArticleId IdType="pubmed">24242746</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeter L.H.H., Gendron T.F., Sias A.C., Jiskoot L.C., Russo S.P., Donker Kaat L., Papma J.M., Panman J.L., van der Ende E.L., Dopper E.G., et al. Poly(GP), neurofilament and grey matter deficits in C9orf72 expansion carriers. Ann. Clin. Transl. Neurol. 2018;5:583&#x2013;597. doi: 10.1002/acn3.559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.559</ArticleId><ArticleId IdType="pmc">PMC5945959</ArticleId><ArticleId IdType="pubmed">29761121</ArticleId></ArticleIdList></Reference><Reference><Citation>Meeter L.H.H., Vijverberg E.G., Del Campo M., Rozemuller A.J.M., Donker Kaat L., de Jong F.J., van der Flier W.M., Teunissen C.E., van Swieten J.C., Pijnenburg Y.A. Clinical value of neurofilament and phospho-tau/tau ratio in the frontotemporal dementia spectrum. Neurology. 2018;90:e1231&#x2013;e1239. doi: 10.1212/WNL.0000000000005261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000005261</ArticleId><ArticleId IdType="pmc">PMC5890612</ArticleId><ArticleId IdType="pubmed">29514947</ArticleId></ArticleIdList></Reference><Reference><Citation>de Jong D., Jansen R.W., Pijnenburg Y.A., van Geel W.J., Borm G.F., Kremer H.P., Verbeek M.M. CSF neurofilament proteins in the differential diagnosis of dementia. J. Neurol. Neurosurg. Psychiatry. 2007;78:936&#x2013;938. doi: 10.1136/jnnp.2006.107326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.107326</ArticleId><ArticleId IdType="pmc">PMC2117885</ArticleId><ArticleId IdType="pubmed">17314187</ArticleId></ArticleIdList></Reference><Reference><Citation>Skillb&#xe4;ck T., Farahmand B., Bartlett J.W., Ros&#xe9;n C., Mattsson N., N&#xe4;gga K., Kilander L., Religa D., Wimo A., Winblad B., et al. CSF neurofilament light differs in neurodegenerative diseases and predicts severity and survival. Neurology. 2014;83:1945&#x2013;1953. doi: 10.1212/WNL.0000000000001015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001015</ArticleId><ArticleId IdType="pubmed">25339208</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson B., Portelius E., Cullen N.C., Sandelius A., Zetterberg H., Andreasson U., H&#xf6;glund K., Irwin D.J., Grossman M., Weintraub D., et al. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels with Cognition in Patients with Dementia, Motor Neuron Disease, and Movement Disorders. JAMA Neurol. 2019;76:318&#x2013;325. doi: 10.1001/jamaneurol.2018.3746.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2018.3746</ArticleId><ArticleId IdType="pmc">PMC6440232</ArticleId><ArticleId IdType="pubmed">30508027</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Karikari T.K., Ashton N., Gazzina S., Premi E., Benussi L., Ghidoni R., Rodriguez J.L., Emer&#x161;i&#x10d; A., Simr&#xe9;n J., et al. Diagnostic and prognostic value of serum NfL and p-Tau181in frontotemporal lobar degeneration. J. Neurol. Neurosurg. Psychiatry. 2020;91:960&#x2013;967. doi: 10.1136/jnnp-2020-323487.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2020-323487</ArticleId><ArticleId IdType="pubmed">32611664</ArticleId></ArticleIdList></Reference><Reference><Citation>Steinacker P., Anderl-Straub S., Diehl-Schmid J., Semler E., Uttner I., Von Arnim C.A.F., Barthel H., Danek A., Fassbender K., Fliessbach K., et al. Serum neurofilament light chain in behavioral variant frontotemporal dementia. Neurology. 2018;91:e1390&#x2013;e1401. doi: 10.1212/WNL.0000000000006318.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006318</ArticleId><ArticleId IdType="pubmed">30209235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke C., Preische O., Deuschle C., Roeben B., Apel A., Barro C., Maia L., Maetzler W., Kuhle J., Synofzik M. Neurofilament light chain in FTD is elevated not only in cerebrospinal fluid, but also in serum. J. Neurol. Neurosurg. Psychiatry. 2016;87:1270&#x2013;1272. doi: 10.1136/jnnp-2015-312972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2015-312972</ArticleId><ArticleId IdType="pubmed">27188986</ArticleId></ArticleIdList></Reference><Reference><Citation>Katisko K., Cajanus A., J&#xe4;&#xe4;skel&#xe4;inen O., Kontkanen A., Hartikainen P., Korhonen V.E., Helisalmi S., Haapasalo A., Koivumaa-Honkanen H., Herukka S.K., et al. Serum neurofilament light chain is a discriminative biomarker between frontotemporal lobar degeneration and primary psychiatric disorders. J. Neurol. 2019;267:162&#x2013;167. doi: 10.1007/s00415-019-09567-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-019-09567-8</ArticleId><ArticleId IdType="pmc">PMC6954884</ArticleId><ArticleId IdType="pubmed">31595378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ljubenkov P.A., Staffaroni A.M., Rojas J.C., Allen I.E., Wang P., Heuer H., Karydas A., Kornak J., Cobigo Y., Seeley W.W., et al. Cerebrospinal fluid biomarkers predict frontotemporal dementia trajectory. Ann. Clin. Transl. Neurol. 2018;5:1250&#x2013;1263. doi: 10.1002/acn3.643.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.643</ArticleId><ArticleId IdType="pmc">PMC6186942</ArticleId><ArticleId IdType="pubmed">30349860</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I., Alcolea D., Montal V., Dols-Icardo O., Mu&#xf1;oz L., de Luna N., Tur&#xf3;n-Sans J., Cort&#xe9;s-Vicente E., S&#xe1;nchez-Saudin&#xf3;s M.B., Subirana A., et al. CSF sAPP&#x3b2;, YKL-40, and NfL along the ALS-FTD spectrum. Neurology. 2018;91:e1619&#x2013;e1628. doi: 10.1212/WNL.0000000000006383.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000006383</ArticleId><ArticleId IdType="pubmed">30291183</ArticleId></ArticleIdList></Reference><Reference><Citation>Goossens J., Bjerke M., Van Mossevelde S., Van den Bossche T., Goeman J., De Vil B., Sieben A., Martin J.J., Cras P., De Deyn P.P., et al. Diagnostic value of cerebrospinal fluid tau, neurofilament, and progranulin in definite frontotemporal lobar degeneration. Alzheimer&#x2019;s Res. Ther. 2018;10:31. doi: 10.1186/s13195-018-0364-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0364-0</ArticleId><ArticleId IdType="pmc">PMC5859717</ArticleId><ArticleId IdType="pubmed">29559004</ArticleId></ArticleIdList></Reference><Reference><Citation>Cajanus A., Katisko K., Kontkanen A., J&#xe4;&#xe4;skel&#xe4;inen O., Hartikainen P., Haapasalo A., Herukka S.K., Vanninen R., Solje E., Hall A., et al. Serum neurofilament light chain in FTLD: Association with C9orf72, clinical phenotype, and prognosis. Ann. Clin. Transl. Neurol. 2020;7:903&#x2013;910. doi: 10.1002/acn3.51041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51041</ArticleId><ArticleId IdType="pmc">PMC7318100</ArticleId><ArticleId IdType="pubmed">32441885</ArticleId></ArticleIdList></Reference><Reference><Citation>Ill&#xe1;n-Gala I., Lleo A., Karydas A., Staffaroni A.M., Zetterberg H., Sivasankaran R., Grinberg L.T., Spina S., Kramer J.H., Ramos E.M., et al. Plasma Tau and Neurofilament Light in Frontotemporal Lobar Degeneration and Alzheimer Disease. Neurology. 2021;96:e671&#x2013;e683. doi: 10.1212/WNL.0000000000011226.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000011226</ArticleId><ArticleId IdType="pmc">PMC7884995</ArticleId><ArticleId IdType="pubmed">33199433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gafson A.R., Barth&#xe9;lemy N.R., Bomont P., Carare R.O., Durham H.D., Julien J.P., Kuhle J., Leppert D., Nixon R.A., Weller R.O., et al. Neurofilaments: Neurobiological foundations for biomarker applications. Brain. 2020;143:1975&#x2013;1998. doi: 10.1093/brain/awaa098.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa098</ArticleId><ArticleId IdType="pmc">PMC7363489</ArticleId><ArticleId IdType="pubmed">32408345</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan A., Sershen H., Veeranna, Basavarajappa B.S., Kumar A., Hashim A., Berg M., Lee J.H., Sato Y., Rao M.V., et al. Neurofilament subunits are integral components of synapses and modulate neurotransmission and behavior in vivo. Mol. Psychiatry. 2015;20:986&#x2013;994. doi: 10.1038/mp.2015.45.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2015.45</ArticleId><ArticleId IdType="pmc">PMC4514553</ArticleId><ArticleId IdType="pubmed">25869803</ArticleId></ArticleIdList></Reference><Reference><Citation>Albargothy N.J., Johnston D.A., MacGregor-Sharp M., Weller R.O., Verma A., Hawkes C.A., Carare R.O. Convective influx/glymphatic system: Tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways. Acta Neuropathol. 2018;136:139&#x2013;152. doi: 10.1007/s00401-018-1862-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1862-7</ArticleId><ArticleId IdType="pmc">PMC6015107</ArticleId><ArticleId IdType="pubmed">29754206</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Del Tredici K., Irwin D.J., Grossman M., Robinson J.L., Toledo J.B., Fang L., Van Deerlin V.M., Ludolph A.C., Lee V.M.-Y., et al. Sequential distribution of pTDP-43 pathology in behavioral variant frontotemporal dementia (bvFTD) Acta Neuropathol. 2014;127:423&#x2013;439. doi: 10.1007/s00401-013-1238-y. Erratum in Acta Neuropathol. 2015, 129, 929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-013-1238-y</ArticleId><ArticleId IdType="pmc">PMC3971993</ArticleId><ArticleId IdType="pubmed">24407427</ArticleId></ArticleIdList></Reference><Reference><Citation>Jo M., Lee S., Jeon Y.M., Kim S., Kwon Y., Kim H.J. The role of TDP-43 propagation in neurodegenerative diseases: Integrating insights from clinical and experimental studies. Exp. Mol. Med. 2020;52:1652&#x2013;1662. doi: 10.1038/s12276-020-00513-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s12276-020-00513-7</ArticleId><ArticleId IdType="pmc">PMC8080625</ArticleId><ArticleId IdType="pubmed">33051572</ArticleId></ArticleIdList></Reference><Reference><Citation>Hasegawa M., Arai T., Nonaka T., Kametani F., Yoshida M., Hashizume Y., Beach T.G., Buratti E., Baralle F., Morita M., et al. Phosphorylated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Ann. Neurol. 2008;64:60&#x2013;70. doi: 10.1002/ana.21425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.21425</ArticleId><ArticleId IdType="pmc">PMC2674108</ArticleId><ArticleId IdType="pubmed">18546284</ArticleId></ArticleIdList></Reference><Reference><Citation>Feneberg E., Steinacker P., Lehnert S., Schneider A., Walther P., Thal D.R., Linsenmeier M., Ludolph A.C., Otto M. Limited role of free TDP-43 as a diagnostic tool in neurodegenerative diseases. Amyotroph. Lateral Scler. Front. Degener. 2014;15:351&#x2013;356. doi: 10.3109/21678421.2014.905606.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.905606</ArticleId><ArticleId IdType="pubmed">24834468</ArticleId></ArticleIdList></Reference><Reference><Citation>Su&#xe1;rez-Calvet M., Kleinberger G., Araque Caballero M., Brendel M., Rominger A., Alcolea D., Fortea J., Lle&#xf3; A., Blesa R., Gispert J.D., et al. sTREM 2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer&#x2019;s disease and associate with neuronal injury markers. EMBO Mol. Med. 2016;8:466&#x2013;476. doi: 10.15252/emmm.201506123.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/emmm.201506123</ArticleId><ArticleId IdType="pmc">PMC5120370</ArticleId><ArticleId IdType="pubmed">26941262</ArticleId></ArticleIdList></Reference><Reference><Citation>Scial&#xf2; C., Tran T.H., Salzano G., Novi G., Caponnetto C., Chi&#xf2; A., Calvo A., Canosa A., Moda F., Caroppo P., et al. TDP-43 real-time quaking induced conversion reaction optimization and detection of seeding activity in CSF of amyotrophic lateral sclerosis and frontotemporal dementia patients. Brain Commun. 2020;2:fcaa142. doi: 10.1093/braincomms/fcaa142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/braincomms/fcaa142</ArticleId><ArticleId IdType="pmc">PMC7566418</ArticleId><ArticleId IdType="pubmed">33094285</ArticleId></ArticleIdList></Reference><Reference><Citation>Jamerlan A.M., Shim K.H., Youn Y.C., Teunissen C., An S.S.A., Scheltens P., Kim S. Increased oligomeric TDP-43 in the plasma of Korean frontotemporal dementia patients with semantic dementia. Alzheimer&#x2019;s Dement. 2023:1&#x2013;8. doi: 10.1002/alz.13127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.13127</ArticleId><ArticleId IdType="pubmed">37200243</ArticleId></ArticleIdList></Reference><Reference><Citation>Doke A.A., Jha S.K. Shapeshifter TDP-43: Molecular mechanism of structural polymorphism, aggregation, phase separation and their modulators. Biophys. Chem. 2023;295:106972. doi: 10.1016/j.bpc.2023.106972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bpc.2023.106972</ArticleId><ArticleId IdType="pubmed">36812677</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkau T.L., Leavitt B.R. Progranulin in neurodegenerative disease. Trends Neurosci. 2014;37:388&#x2013;398. doi: 10.1016/j.tins.2014.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2014.04.003</ArticleId><ArticleId IdType="pubmed">24800652</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkau T.L., Neal S.J., Milnerwood A., Mew A., Hill A.M., Orban P., Gregg J., Lu G., Feldman H.H., Mackenzie I.R., et al. Synaptic dysfunction in progranulin-deficient mice. Neurobiol. Dis. 2012;45:711&#x2013;722. doi: 10.1016/j.nbd.2011.10.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.10.016</ArticleId><ArticleId IdType="pubmed">22062772</ArticleId></ArticleIdList></Reference><Reference><Citation>Petkau T.L., Zhu S., Lu G., Fernando S., Cynader M., Leavitt B.R. Sensitivity to neurotoxic stress is not increased in progranulin-deficient mice. Neurobiol. Aging. 2013;34:2548&#x2013;2550. doi: 10.1016/j.neurobiolaging.2013.04.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2013.04.019</ArticleId><ArticleId IdType="pubmed">23702345</ArticleId></ArticleIdList></Reference><Reference><Citation>Colombrita C., Onesto E., Megiorni F., Pizzuti A., Baralle F.E., Buratti E., Silani V., Ratti A. TDP-43 and FUS RNA-binding Proteins Bind Distinct Sets of Cytoplasmic Messenger RNAs and Differently Regulate Their Post-transcriptional Fate in Motoneuron-like Cells. J. Biol. Chem. 2012;287:15635&#x2013;15647. doi: 10.1074/jbc.M111.333450.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.333450</ArticleId><ArticleId IdType="pmc">PMC3346140</ArticleId><ArticleId IdType="pubmed">22427648</ArticleId></ArticleIdList></Reference><Reference><Citation>Petoukhov E., Fernando S., Mills F., Shivji F., Hunter D., Krieger C., Silverman M.A., Bamji S.X. Activity-dependent secretion of progranulin from synapses. Pt 23J. Cell Sci. 2013;126:5412&#x2013;5421. doi: 10.1242/jcs.132076.</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.132076</ArticleId><ArticleId IdType="pubmed">24046442</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;rtvelyessy P., Heinze H.J., Prudlo J., Bittner D. CSF Biomarkers of Neurodegeneration in Progressive Non-fluent Aphasia and Other Forms of Frontotemporal Dementia: Clues for Pathomechanisms? Front. Neurol. 2018;9:504. doi: 10.3389/fneur.2018.00504.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2018.00504</ArticleId><ArticleId IdType="pmc">PMC6036143</ArticleId><ArticleId IdType="pubmed">30013506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilke C., Gillardon F., Deuschle C., Dubois E., Hobert M.A., M&#xfc;ller vom Hagen J., Kr&#xfc;ger S., Biskup S., Blauwendraat C., Hruscha M., et al. Serum Levels of Progranulin Do Not Reflect Cerebrospinal Fluid Levels in Neurodegenerative Disease. Curr. Alzheimer Res. 2016;13:654&#x2013;662. doi: 10.2174/1567205013666160314151247.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1567205013666160314151247</ArticleId><ArticleId IdType="pubmed">26971930</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghidoni R., Benussi L., Glionna M., Franzoni M., Binetti G. Low plasma progranulin levels predict progranulin mutations in frontotemporal lobar degeneration. Neurology. 2008;71:1235&#x2013;1239. doi: 10.1212/01.wnl.0000325058.10218.fc.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000325058.10218.fc</ArticleId><ArticleId IdType="pubmed">18768919</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui H., Zhang J., Makinson S.R., Cahill M.K., Kelley K.W., Huang H.Y., Shang Y., Oldham M.C., Martens L.H., Gao F., et al. Progranulin Deficiency Promotes Circuit-Specific Synaptic Pruning by Microglia via Complement Activation. Cell. 2016;165:921&#x2013;935. doi: 10.1016/j.cell.2016.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2016.04.001</ArticleId><ArticleId IdType="pmc">PMC4860138</ArticleId><ArticleId IdType="pubmed">27114033</ArticleId></ArticleIdList></Reference><Reference><Citation>Jack C.R., Jr., Bennett D.A., Blennow K., Carrillo M.C., Dunn B., Haeberlein S.B., Holtzman D.M., Jagust W., Jessen F., Karlawish J., et al. NIA-AA Research Framework: Toward a biological definition of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2018;14:535&#x2013;562. doi: 10.1016/j.jalz.2018.02.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2018.02.018</ArticleId><ArticleId IdType="pmc">PMC5958625</ArticleId><ArticleId IdType="pubmed">29653606</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Z., Fu L.P., Zhang N., Zhao X., Liu S., Zuo C., Cai L., Wang Y., Gao S., Ai L., et al. Amyloid PET in Dementia Syndromes: A Chinese Multicenter Study. J. Nucl. Med. 2020;61:1814&#x2013;1819. doi: 10.2967/jnumed.119.240325. Erratum in J. Nucl. Med. 2022, 63, 100&#x2013;1000.</Citation><ArticleIdList><ArticleId IdType="doi">10.2967/jnumed.119.240325</ArticleId><ArticleId IdType="pubmed">32385166</ArticleId></ArticleIdList></Reference><Reference><Citation>Hellwig S., Frings L., Bormann T., Vach W., Buchert R., Meyer P.T. Amyloid imaging for differential diagnosis of dementia: Incremental value compared to clinical diagnosis and [18F]FDG PET. Eur. J. Nucl. Med. Mol. Imaging. 2019;46:312&#x2013;323. doi: 10.1007/s00259-018-4111-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00259-018-4111-3</ArticleId><ArticleId IdType="pmc">PMC6333717</ArticleId><ArticleId IdType="pubmed">30094462</ArticleId></ArticleIdList></Reference><Reference><Citation>Struyfs H., Van Broeck B., Timmers M., Fransen E., Sleegers K., Van Broeckhoven C., De Deyn P.P., Streffer J.R., Mercken M., Engelborghs S. Diagnostic Accuracy of Cerebrospinal Fluid Amyloid-&#x3b2; Isoforms for Early and Differential Dementia Diagnosis. J. Alzheimer&#x2019;s Dis. 2015;45:813&#x2013;822. doi: 10.3233/JAD-141986.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-141986</ArticleId><ArticleId IdType="pubmed">25633670</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana A., Di Lorenzo F., Belli L., Sancesario G., Toniolo S., Sallustio F., Sancesario G.M., Koch G. Cerebrospinal Fluid A&#x3b2;42 Levels: When Physiological Become Pathological State. CNS Neurosci. Ther. 2015;21:921&#x2013;925. doi: 10.1111/cns.12476.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/cns.12476</ArticleId><ArticleId IdType="pmc">PMC6493161</ArticleId><ArticleId IdType="pubmed">26555572</ArticleId></ArticleIdList></Reference><Reference><Citation>Alcolea D., Vilaplana E., Su&#xe1;rez-Calvet M., Ill&#xe1;n-Gala I., Blesa R., Clarim&#xf3;n J., Llad&#xf3; A., S&#xe1;nchez-Valle R., Molinuevo J.L., Garc&#xed;a-Ribas G., et al. CSF sAPP&#x3b2;, YKL-40, and neurofilament light in frontotemporal lobar degeneration. Neurology. 2017;89:178&#x2013;188. doi: 10.1212/WNL.0000000000004088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004088</ArticleId><ArticleId IdType="pubmed">28592456</ArticleId></ArticleIdList></Reference><Reference><Citation>Skillb&#xe4;ck T., Farahmand B.Y., Ros&#xe9;n C., Mattsson N., N&#xe4;gga K., Kilander L., Religa D., Wimo A., Winblad B., Schott J.M., et al. Cerebrospinal fluid tau and amyloid-&#x3b2;1-42in patients with dementia. Pt 9Brain. 2015;138:2716&#x2013;2731. doi: 10.1093/brain/awv181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awv181</ArticleId><ArticleId IdType="pubmed">26133663</ArticleId></ArticleIdList></Reference><Reference><Citation>Foiani M.S., Woollacott I.O., Heller C., Bocchetta M., Heslegrave A., Dick K.M., Russell L.L., Marshall C.R., Mead S., Schott J.M., et al. Plasma tau is increased in frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry. 2018;89:804&#x2013;807. doi: 10.1136/jnnp-2017-317260.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-317260</ArticleId><ArticleId IdType="pmc">PMC6204947</ArticleId><ArticleId IdType="pubmed">29440230</ArticleId></ArticleIdList></Reference><Reference><Citation>Ntymenou S., Tsantzali I., Kalamatianos T., Voumvourakis K.I., Kapaki E., Tsivgoulis G., Stranjalis G., Paraskevas G.P. Blood Biomarkers in Frontotemporal Dementia: Review and Meta-Analysis. Brain Sci. 2021;11:244. doi: 10.3390/brainsci11020244.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci11020244</ArticleId><ArticleId IdType="pmc">PMC7919273</ArticleId><ArticleId IdType="pubmed">33672008</ArticleId></ArticleIdList></Reference><Reference><Citation>Thijssen E.H., Verberk I.M.W., Stoops E., Boxer A.L., Teunissen C.E. Amyloid, pTau, NfL, and GFAP as biomarkers for Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2020;16:e038179. doi: 10.1002/alz.038179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.038179</ArticleId></ArticleIdList></Reference><Reference><Citation>Pereira J.B., Janelidze S., Smith R., Mattsson-Carlgren N., Palmqvist S., Teunissen C.E., Zetterberg H., Stomrud E., Ashton N.J., Blennow K., et al. Plasma GFAP is an early marker of amyloid-&#x3b2; but not tau pathology in Alzheimer&#x2019;s disease. Brain. 2021;144:3505&#x2013;3516. doi: 10.1093/brain/awab223.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awab223</ArticleId><ArticleId IdType="pmc">PMC8677538</ArticleId><ArticleId IdType="pubmed">34259835</ArticleId></ArticleIdList></Reference><Reference><Citation>Carmona S., Zahs K., Wu E., Dakin K., Bras J., Guerreiro R. The role of TREM2 in Alzheimer&#x2019;s disease and other neurodegenerative disorders. Lancet Neurol. 2018;17:721&#x2013;730. doi: 10.1016/S1474-4422(18)30232-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(18)30232-1</ArticleId><ArticleId IdType="pubmed">30033062</ArticleId></ArticleIdList></Reference><Reference><Citation>Woollacott I.O.C., Nicholas J.M., Heslegrave A., Heller C., Foiani M.S., Dick K.M., Russell L.L., Paterson R.W., Keshavan A., Fox N.C., et al. Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup. Alzheimer&#x2019;s Res. Ther. 2018;10:79. doi: 10.1186/s13195-018-0405-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-018-0405-8</ArticleId><ArticleId IdType="pmc">PMC6094471</ArticleId><ArticleId IdType="pubmed">30111356</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Y.J., Siow I., Saffari S.E., Ting S.K.S., Li Z., Kandiah N., Tan L.C.S., Tan E.K., Ng A.S.L. Plasma Soluble ST2 Levels Are Higher in Neurodegenerative Disorders and Associated with Poorer Cognition. J. Alzheimer&#x2019;s Dis. 2023;92:573&#x2013;580. doi: 10.3233/JAD-221072.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-221072</ArticleId><ArticleId IdType="pubmed">36776067</ArticleId></ArticleIdList></Reference><Reference><Citation>Foiani M.S., Cicognola C., Ermann N., Woollacott I.O.C., Heller C., Heslegrave A.J., Keshavan A., Paterson R.W., Ye K., Kornhuber J., et al. Searching for novel cerebrospinal fluid biomarkers of tau pathology in frontotemporal dementia: An elusive quest. J. Neurol. Neurosurg. Psychiatry. 2019;90:740&#x2013;746. doi: 10.1136/jnnp-2018-319266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-319266</ArticleId><ArticleId IdType="pmc">PMC6585261</ArticleId><ArticleId IdType="pubmed">30981993</ArticleId></ArticleIdList></Reference><Reference><Citation>Bridel C., van Gils J.H.M., Miedema S.S.M., Hoozemans J.J.M., Pijnenburg Y.A.L., Smit A.B., Rozemuller A.J.M., Abeln S., Teunissen C.E. Clusters of co-abundant proteins in the brain cortex associated with fronto-temporal lobar degeneration. Alzheimer&#x2019;s Res. Ther. 2023;15:59. doi: 10.1186/s13195-023-01200-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-023-01200-1</ArticleId><ArticleId IdType="pmc">PMC10035199</ArticleId><ArticleId IdType="pubmed">36949537</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo F., Oliviero A., Guerra A., Fried P.J. Editorial: Non-invasive Brain Stimulation for Neurodegenerative Disorders: From Investigation to Therapeutic Application. Front. Neurol. 2022;13:820942. doi: 10.3389/fneur.2022.820942.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2022.820942</ArticleId><ArticleId IdType="pmc">PMC8929759</ArticleId><ArticleId IdType="pubmed">35309570</ArticleId></ArticleIdList></Reference><Reference><Citation>Casula E.P., Borghi I., Maiella M., Pellicciari M.C., Bonn&#xec; S., Mencarelli L., Assogna M., D&#x2019;Acunto A., Di Lorenzo F., Spampinato D.A., et al. Regional Precuneus Cortical Hyperexcitability in Alzheimer&#x2019;s Disease Patients. Ann. Neurol. 2023;93:371&#x2013;383. doi: 10.1002/ana.26514.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.26514</ArticleId><ArticleId IdType="pmc">PMC10092632</ArticleId><ArticleId IdType="pubmed">36134540</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo F., Bonn&#xec; S., Picazio S., Motta C., Caltagirone C., Martorana A., Koch G. Effects of Cerebellar Theta Burst Stimulation on Contralateral Motor Cortex Excitability in Patients with Alzheimer&#x2019;s Disease. Brain Topogr. 2020;33:613&#x2013;617. doi: 10.1007/s10548-020-00781-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10548-020-00781-6</ArticleId><ArticleId IdType="pubmed">32564167</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo F., Koch G. Synaptic impairment: The new battlefield of Alzheimer&#x2019;s disease. Alzheimer&#x2019;s Dement. 2021;17:314&#x2013;315. doi: 10.1002/alz.12189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/alz.12189</ArticleId><ArticleId IdType="pubmed">32946657</ArticleId></ArticleIdList></Reference><Reference><Citation>Murley A.G., Rowe J.B. Neurotransmitter deficits from frontotemporal lobar degeneration. Brain. 2018;141:1263&#x2013;1285. doi: 10.1093/brain/awx327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx327</ArticleId><ArticleId IdType="pmc">PMC5917782</ArticleId><ArticleId IdType="pubmed">29373632</ArticleId></ArticleIdList></Reference><Reference><Citation>Murley A.G., Rouse M.A., Jones P.S., Ye R., Hezemans F.H., O&#x2019;Callaghan C., Frangou P., Kourtzi Z., Rua C., Carpenter T.A., et al. GABA and glutamate deficits from frontotemporal lobar degeneration are associated with disinhibition. Brain. 2020;143:3449&#x2013;3462. doi: 10.1093/brain/awaa305.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa305</ArticleId><ArticleId IdType="pmc">PMC7719029</ArticleId><ArticleId IdType="pubmed">33141154</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierantozzi M., Panella M., Palmieri M.G., Koch G., Giordano A., Marciani M.G., Bernardi G., Stanzione P., Stefani A. Different TMS patterns of intracortical inhibition in early onset Alzheimer dementia and frontotemporal dementia. Clin. Neurophysiol. 2004;115:2410&#x2013;2418. doi: 10.1016/j.clinph.2004.04.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinph.2004.04.022</ArticleId><ArticleId IdType="pubmed">15351384</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lazzaro V., Pilato F., Dileone M., Saturno E., Oliviero A., Marra C., Daniele A., Ranieri F., Gainotti G., Tonali P.A. In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology. 2006;66:1111&#x2013;1113. doi: 10.1212/01.wnl.0000204183.26231.23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000204183.26231.23</ArticleId><ArticleId IdType="pubmed">16606932</ArticleId></ArticleIdList></Reference><Reference><Citation>Alberici A., Bonato C., Calabria M., Agosti C., Zanetti O., Miniussi C., Padovani A., Rossini P.M., Borroni B. The contribution of TMS to frontotemporal dementia variants. Acta Neurol. Scand. 2008;118:275&#x2013;280. doi: 10.1111/j.1600-0404.2008.01017.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1600-0404.2008.01017.x</ArticleId><ArticleId IdType="pubmed">18397363</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell J.R., Kiernan M.C., Vucic S., Hodges J.R. Motor Neuron dysfunction in frontotemporal dementia. Pt 9Brain. 2011;134:2582&#x2013;2594. doi: 10.1093/brain/awr195.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awr195</ArticleId><ArticleId IdType="pubmed">21840887</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Di Lorenzo F., Dell&#x2019;Era V., Cosseddu M., Alberici A., Caratozzolo S., Cotelli M.S., Micheli A., Rozzini L., Depari A., et al. Transcranial magnetic stimulation distinguishes Alzheimer disease from frontotemporal dementia. Neurology. 2017;89:665&#x2013;672. doi: 10.1212/WNL.0000000000004232.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000004232</ArticleId><ArticleId IdType="pubmed">28747446</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae J.S., Ferguson M., Tan R., Mioshi E., Simon N., Burrell J., Vucic S., Hodges J.R., Kiernan M.C., Hornberger M. Dissociation of Structural and Functional Integrities of the Motor System in Amyotrophic Lateral Sclerosis and Behavioral-Variant Frontotemporal Dementia. J. Clin. Neurol. 2016;12:209&#x2013;217. doi: 10.3988/jcn.2016.12.2.209.</Citation><ArticleIdList><ArticleId IdType="doi">10.3988/jcn.2016.12.2.209</ArticleId><ArticleId IdType="pmc">PMC4828568</ArticleId><ArticleId IdType="pubmed">26932257</ArticleId></ArticleIdList></Reference><Reference><Citation>Martorana A., Di Lorenzo F., Manenti G., Semprini R., Koch G. Homotaurine Induces Measurable Changes of Short Latency Afferent Inhibition in a Group of Mild Cognitive Impairment Individuals. Front. Aging Neurosci. 2014;6:254. doi: 10.3389/fnagi.2014.00254.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnagi.2014.00254</ArticleId><ArticleId IdType="pmc">PMC4172065</ArticleId><ArticleId IdType="pubmed">25295005</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonn&#xec; S., Ponzo V., Di Lorenzo F., Caltagirone C., Koch G. Real-time activation of central cholinergic circuits during recognition memory. Eur. J. Neurosci. 2017;45:1485&#x2013;1489. doi: 10.1111/ejn.13588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ejn.13588</ArticleId><ArticleId IdType="pubmed">28444832</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Dell&#x2019;Era V., Cosseddu M., Cantoni V., Cotelli M.S., Cotelli M., Manenti R., Benussi L., Brattini C., Alberici A., et al. Transcranial stimulation in frontotemporal dementia: A randomized, double-blind, sham-controlled trial. Alzheimer&#x2019;s Dement. 2020;6:e12033. doi: 10.1002/trc2.12033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12033</ArticleId><ArticleId IdType="pmc">PMC7253155</ArticleId><ArticleId IdType="pubmed">32490143</ArticleId></ArticleIdList></Reference><Reference><Citation>Benussi A., Ashton N.J., Karikari T.K., Alberici A., Saraceno C., Ghidoni R., Benussi L., Zetterberg H., Blennow K., Borroni B. Prodromal frontotemporal dementia: Clinical features and predictors of progression. Alzheimer&#x2019;s Res. Ther. 2021;13:188. doi: 10.1186/s13195-021-00932-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-021-00932-2</ArticleId><ArticleId IdType="pmc">PMC8594126</ArticleId><ArticleId IdType="pubmed">34782010</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer A.L., Gold M., Huey E., Gao F.B., Burton E.A., Chow T., Kao A., Leavitt B.R., Lamb B., Grether M., et al. Frontotemporal degeneration, the next therapeutic frontier: Molecules and animal models for frontotemporal degeneration drug development. Alzheimer&#x2019;s Dement. 2013;9:176&#x2013;188. doi: 10.1016/j.jalz.2012.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jalz.2012.03.002</ArticleId><ArticleId IdType="pmc">PMC3542408</ArticleId><ArticleId IdType="pubmed">23043900</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandt R., Gergou A., Wacker I., Fath T., Hutter H. A Caenorhabditis elegans model of tau hyperphosphorylation: Induction of developmental defects by transgenic overexpression of Alzheimer&#x2019;s disease-like modified tau. Neurobiol. Aging. 2009;30:22&#x2013;33. doi: 10.1016/j.neurobiolaging.2007.05.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2007.05.011</ArticleId><ArticleId IdType="pubmed">17590239</ArticleId></ArticleIdList></Reference><Reference><Citation>Loewen C.A., Feany M.B. The Unfolded Protein Response Protects from Tau Neurotoxicity In Vivo. PLoS ONE. 2010;5:e13084. doi: 10.1371/journal.pone.0013084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0013084</ArticleId><ArticleId IdType="pmc">PMC2947516</ArticleId><ArticleId IdType="pubmed">20927324</ArticleId></ArticleIdList></Reference><Reference><Citation>Sager J.J., Bai Q., Burton E.A. Transgenic zebrafish models of neurodegenerative diseases. Brain Struct. Funct. 2010;214:285&#x2013;302. doi: 10.1007/s00429-009-0237-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00429-009-0237-1</ArticleId><ArticleId IdType="pubmed">20162303</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed R.M., Irish M., van Eersel J., Ittner A., Ke Y.D., Volkerling A., van der Hoven J., Tanaka K., Karl T., Kassiou M., et al. Mouse models of frontotemporal dementia: A comparison of phenotypes with clinical symptomatology. Neurosci. Biobehav. Rev. 2017;74 Pt A:126&#x2013;138. doi: 10.1016/j.neubiorev.2017.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neubiorev.2017.01.004</ArticleId><ArticleId IdType="pubmed">28088537</ArticleId></ArticleIdList></Reference><Reference><Citation>Noble W., Hanger D.P., Gallo J.M. Transgenic Mouse Models of Tauopathy in Drug Discovery. CNS Neurol. Disord. Drug Targets. 2010;9:403&#x2013;428. doi: 10.2174/187152710791556131.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/187152710791556131</ArticleId><ArticleId IdType="pubmed">20522014</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu Y.F., Gendron T.F., Zhang Y.J., Lin W.L., D&#x2019;Alton S., Sheng H., Casey M.C., Tong J., Knight J., Yu X., et al. Wild-type human TDP-43 expression causes TDP-43 phosphorylation, mitochondrial aggregation, motor deficits, and early mortality in transgenic mice. J. Neurosci. 2010;30:10851&#x2013;10859. doi: 10.1523/JNEUROSCI.1630-10.2010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.1630-10.2010</ArticleId><ArticleId IdType="pmc">PMC3056148</ArticleId><ArticleId IdType="pubmed">20702714</ArticleId></ArticleIdList></Reference><Reference><Citation>Kayasuga Y., Chiba S., Suzuki M., Kikusui T., Matsuwaki T., Yamanouchi K., Kotaki H., Horai R., Iwakura Y., Nishihara M. Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav. Brain Res. 2007;185:110&#x2013;118. doi: 10.1016/j.bbr.2007.07.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2007.07.020</ArticleId><ArticleId IdType="pubmed">17764761</ArticleId></ArticleIdList></Reference><Reference><Citation>Chew J., Gendron T.F., Prudencio M., Sasaguri H., Zhang Y.J., Castanedes-Casey M., Lee C.W., Jansen-West K., Kurti A., Murray M.E., et al. C9ORF72 repeat expansions in mice cause TDP-43 pathology, neuronal loss, and behavioral deficits. Science. 2015;348:1151&#x2013;1154. doi: 10.1126/science.aaa9344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa9344</ArticleId><ArticleId IdType="pmc">PMC4692360</ArticleId><ArticleId IdType="pubmed">25977373</ArticleId></ArticleIdList></Reference><Reference><Citation>McCauley M.E., Baloh R.H. Inflammation in ALS/FTD pathogenesis. Acta Neuropathol. 2019;137:715&#x2013;730. doi: 10.1007/s00401-018-1933-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-018-1933-9</ArticleId><ArticleId IdType="pmc">PMC6482122</ArticleId><ArticleId IdType="pubmed">30465257</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu W., Zhao L., Blackman B., Parmar M., Wong M.Y., Woo T., Yu F., Chiuchiolo M.J., Sondhi D., Kaminsky S.M., et al. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice. J. Neurosci. 2016;36:12425&#x2013;12435. doi: 10.1523/JNEUROSCI.2016-16.2016. Erratum in J. Neurosci. 2017, 37, 3734.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.2016-16.2016</ArticleId><ArticleId IdType="pmc">PMC6601971</ArticleId><ArticleId IdType="pubmed">27927959</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhinn H., Tatton N., McCaughey S., Kurnellas M., Rosenthal A. Progranulin as a therapeutic target in neurodegenerative diseases. Trends Pharmacol. Sci. 2022;43:641&#x2013;652. doi: 10.1016/j.tips.2021.11.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tips.2021.11.015</ArticleId><ArticleId IdType="pubmed">35039149</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran H., Moazami M.P., Yang H., McKenna-Yasek D., Douthwright C.L., Pinto C., Metterville J., Shin M., Sanil N., Dooley C., et al. Suppression of mutant C9orf72 expression by a potent mixed backbone antisense oligonucleotide. Nat. Med. 2022;28:117&#x2013;124. doi: 10.1038/s41591-021-01557-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01557-6</ArticleId><ArticleId IdType="pmc">PMC8861976</ArticleId><ArticleId IdType="pubmed">34949835</ArticleId></ArticleIdList></Reference><Reference><Citation>Antczak J., Kowalska K., Klimkowicz-Mrowiec A., Wach B., Kasprzyk K., Banach M., Rze&#x17a;nicka-Brzegowy K., Kubica J., S&#x142;owik A. Repetitive transcranial magnetic stimulation for the treatment of cognitive impairment in frontotemporal dementia: An open-label pilot study. Neuropsychiatr. Dis. Treat. 2018;14:749&#x2013;755. doi: 10.2147/NDT.S153213.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/NDT.S153213</ArticleId><ArticleId IdType="pmc">PMC5856301</ArticleId><ArticleId IdType="pubmed">29559782</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M., Sprugnoli G., Press D., Dickerson B., Macone J., Bonn&#xec; S., Borghi I., Connor A., Hoffman M., Grover N., et al. Gamma-induction in frontotemporal dementia (GIFTeD) randomized placebo-controlled trial: Rationale, noninvasive brain stimulation protocol, and study design. Alzheimer&#x2019;s Dement. 2022;7:e12219. doi: 10.1002/trc2.12219.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/trc2.12219</ArticleId><ArticleId IdType="pmc">PMC8813035</ArticleId><ArticleId IdType="pubmed">35141396</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M., Di Lorenzo F., Martorana A., Koch G. Synaptic Effects of Palmitoylethanolamide in Neurodegenerative Disorders. Biomolecules. 2022;12:1161. doi: 10.3390/biom12081161.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/biom12081161</ArticleId><ArticleId IdType="pmc">PMC9405819</ArticleId><ArticleId IdType="pubmed">36009055</ArticleId></ArticleIdList></Reference><Reference><Citation>Assogna M., Casula E.P., Borghi I., Bonn&#xec; S., Sam&#xe0; D., Motta C., Di Lorenzo F., D&#x2019;acunto A., Porrazzini F., Minei M., et al. Effects of Palmitoylethanolamide Combined with Luteoline on Frontal Lobe Functions, High Frequency Oscillations, and GABAergic Transmission in Patients with Frontotemporal Dementia. J. Alzheimer&#x2019;s Dis. 2020;76:1297&#x2013;1308. doi: 10.3233/JAD-200426.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-200426</ArticleId><ArticleId IdType="pubmed">32623398</ArticleId></ArticleIdList></Reference><Reference><Citation>Shinagawa S., Nakajima S., Plitman E., Graff-Guerrero A., Mimura M., Nakayama K., Miller B.L. Non-Pharmacological Management for Patients with Frontotemporal Dementia: A Systematic Review. J. Alzheimer&#x2019;s Dis. 2015;45:283&#x2013;293. doi: 10.3233/JAD-142109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3233/JAD-142109</ArticleId><ArticleId IdType="pubmed">25737152</ArticleId></ArticleIdList></Reference><Reference><Citation>Wylie M.A., Shnall A., Onyike C.U., Huey E.D. Management of frontotemporal dementia in mental health and multidisciplinary settings. Int. Rev. Psychiatry. 2013;25:230&#x2013;236. doi: 10.3109/09540261.2013.776949.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09540261.2013.776949</ArticleId><ArticleId IdType="pmc">PMC3929950</ArticleId><ArticleId IdType="pubmed">23611352</ArticleId></ArticleIdList></Reference><Reference><Citation>Boxer A.L., Boeve B.F. Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies. Alzheimer Dis. Assoc. Disord. 2007;21:S79&#x2013;S87. doi: 10.1097/WAD.0b013e31815c345e.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0b013e31815c345e</ArticleId><ArticleId IdType="pubmed">18090429</ArticleId></ArticleIdList></Reference><Reference><Citation>Huey E.D., Putnam K.T., Grafman J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006;66:17&#x2013;22. doi: 10.1212/01.wnl.0000191304.55196.4d.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/01.wnl.0000191304.55196.4d</ArticleId><ArticleId IdType="pmc">PMC4499854</ArticleId><ArticleId IdType="pubmed">16401839</ArticleId></ArticleIdList></Reference><Reference><Citation>Gambogi L.B., Guimar&#xe3;es H.C., de Souza L.C., Caramelli P. Treatment of the behavioral variant of frontotemporal dementia: A narrative review. Dement. Neuropsychol. 2021;15:331&#x2013;338. doi: 10.1590/1980-57642021dn15-030004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1980-57642021dn15-030004</ArticleId><ArticleId IdType="pmc">PMC8485641</ArticleId><ArticleId IdType="pubmed">34630920</ArticleId></ArticleIdList></Reference><Reference><Citation>Moretti R., Torre P., Antonello R.M., Cazzato G., Griggio S., Bava A. Olanzapine as a treatment of neuropsychiatric disorders of Alzheimer&#x2019;s disease and other dementias: A 24-month follow-up of 68 patients. Am. J. Alzheimer&#x2019;s Dis. Other Dementiasr. 2003;18:205&#x2013;214. doi: 10.1177/153331750301800410.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/153331750301800410</ArticleId><ArticleId IdType="pubmed">12955785</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Lorenzo F., Motta C., Caltagirone C., Koch G., Mercuri N.B., Martorana A. Lacosamide in the Management of Behavioral Symptoms in Frontotemporal Dementia: A 2-Case Report. Alzheimer Dis. Assoc. Disord. 2018;32:364&#x2013;365. doi: 10.1097/WAD.0000000000000245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WAD.0000000000000245</ArticleId><ArticleId IdType="pubmed">29389672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>